JPH10265350A - Hair tonic - Google Patents

Hair tonic

Info

Publication number
JPH10265350A
JPH10265350A JP9091537A JP9153797A JPH10265350A JP H10265350 A JPH10265350 A JP H10265350A JP 9091537 A JP9091537 A JP 9091537A JP 9153797 A JP9153797 A JP 9153797A JP H10265350 A JPH10265350 A JP H10265350A
Authority
JP
Japan
Prior art keywords
extract
hair
component
growth
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9091537A
Other languages
Japanese (ja)
Inventor
Eriko Takeoka
永里子 武岡
Chika Hamada
千加 浜田
Jun Suzuki
順 鈴木
Yosuke Nakazawa
陽介 中沢
Masahiro Tajima
正裕 田島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP9091537A priority Critical patent/JPH10265350A/en
Publication of JPH10265350A publication Critical patent/JPH10265350A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a hair tonic capable of synergistically manifesting further hair growing activities by using the hair tonic with a component recognized as having activities for extending a hair growth period in combination. SOLUTION: This hair tonic contains an ingredient having activities for inhibiting testosterone-5α-reductase and an ingredient having activities capable of maintaining and extending the growth period in hair cycle, especially the ingredient having activities capable of maintaining and extending the growth period in the hair cycle as active ingredients. The hair tonic manifests very superior hair growing activities because both ingredients synergistically manifests the activities.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は育毛剤に関する技術
分野に属する発明である。より詳細には、テストステロ
ン−5α−レダクターゼを阻害する作用を有する成分及
び毛周期における成長期を維持若しくは延長する作用を
有する成分を有効成分とすることによって、相乗的な育
毛作用を示す育毛剤に関する。
TECHNICAL FIELD [0001] The present invention is an invention belonging to the technical field related to a hair restorer. More specifically, the present invention relates to a hair restorer having a synergistic hair-growth effect by using a component having an activity of inhibiting testosterone-5α-reductase and a component having an activity of maintaining or prolonging the anagen phase in the hair cycle as active ingredients. .

【0002】[0002]

【従来の技術】高齢化社会、ストレス社会といわれる現
代社会では、頭部毛髪が様々な原因により脱毛の危機に
さらされる機会がますます多くなってきている。これに
対応して、より優れた「育毛剤」を提供すべく様々な試
みがなされている。育毛料が毛髪に与える効果として主
なものに、発毛誘導効果(発毛促進効果,成長期誘導
効果),毛髪を太くする効果,毛髪成長期延長効
果,テストステロン−5α−レダクターゼ阻害効果,
血行促進効果,殺菌効果,フケ防止効果,保湿
効果,抗酸化効果等の効果が挙げられる。
2. Description of the Related Art In a modern society referred to as an aging society or a stressed society, there are more and more opportunities for head hair to be exposed to the risk of hair loss due to various causes. In response to this, various attempts have been made to provide a more excellent “hair restorer”. The main effects of the hair restorer on the hair include a hair growth-inducing effect (a hair growth-promoting effect, a growth period-inducing effect), a thickening effect, a hair growth period extending effect, a testosterone-5α-reductase inhibitory effect,
The effects include a blood circulation promoting effect, a bactericidal effect, a dandruff preventing effect, a moisturizing effect, an antioxidant effect, and the like.

【0003】しかしながら、前記のように種々の試みが
なされているにもかかわらず、従来の育毛料では、その
脱毛防止,発毛効果等の育毛作用は必ずしも十分なもの
ではなかった。これはおそらく脱毛の原因がさまざまで
あり、また発毛の機構も非常に複雑であるためと考えら
れている。今まで提供されている「育毛料」は、脱毛を
比較的大雑把な概念、言い換えれば漫然と「脱毛」とい
う現象のみを捉えて開発されており、そのメカニズムに
まで突っ込んで着目して開発されたものは決して多くな
い。その大きな理由が、これらのメカニズムに着目した
育毛効果を簡便に検定することが可能な育毛薬剤検定方
法が十分に提供されていなかったという面を否定できな
いことである。特に上記の毛髪成長期延長効果を検定
する育毛薬剤検定方法の確立は難しく、結果としてこれ
まで提供されてきた育毛料は、毛周期の成長期へと毛髪
を誘導して育毛する上記発毛誘導効果に着目したもの
が多かった。
[0003] However, despite various attempts as described above, conventional hair restorers have not always had sufficient hair restoring effects such as hair loss prevention and hair growth effects. This is probably due to various causes of hair loss and the very complex mechanism of hair growth. The `` hair restoration '' provided so far has been developed by capturing only the relatively rough concept of hair loss, in other words, simply and simply the phenomenon of `` hair loss '', and was developed by focusing on the mechanism Is not much. The major reason is that it cannot be denied that a hair-growth drug assay method capable of simply testing the hair-growth effect focusing on these mechanisms has not been sufficiently provided. In particular, it is difficult to establish a hair-growth drug assay method for assaying the above-described hair growth period prolonging effect. As a result, the hair growth products provided so far induce the hair growth to the growth period of the hair cycle and the hair growth induction. Many focused on the effects.

【0004】[0004]

【発明が解決しようとする課題】本発明者は、従来この
ように漫然と配合されがちであった育毛成分を、上記し
た脱毛のメカニズムに考慮して配合することができれ
ば、一層の育毛効果を発揮し得る育毛剤が提供される得
ると考えた。その考え方の一つとして、上記の毛髪成
長期延長効果を検定する育毛薬剤検定方法を確立させ
て、この毛髪成長期延長効果を有する成分を見出し、こ
の成分とこれ以外の他の効果を有する成分とを組み合わ
せて有効成分とする育毛剤を提供することで、それぞれ
の効果が同時に毛髪に対して働く相乗効果を発揮する育
毛剤を提供する、という考え方が挙げられる。
The inventor of the present invention has shown that a hair-growth component that has been conventionally tended to be intuitively blended can be further improved if it can be formulated in consideration of the above-mentioned hair loss mechanism. It was thought that a hair restorer could be provided. One of the ideas is to establish a hair growth stimulating method for assaying the above-described hair growth period extending effect, find a component having this hair growth period extending effect, and find this component and a component having other effects. By providing a hair restorer as an active ingredient in combination with the above, the idea of providing a hair restorer exhibiting a synergistic effect in which the respective effects simultaneously act on the hair is provided.

【0005】このような技術的な流れの中で、本発明者
らは上記の毛髪成長期延長効果を簡便かつ的確に検定
し得る育毛薬剤検定方法を確立した。そこで、本発明が
解決すべき課題は、この育毛薬剤検定方法等で上記の
毛髪成長期延長効果が認められる成分と組み合わせて有
効成分とすることで、相乗的に一層の育毛効果が発揮さ
れ得る育毛剤を提供することにある。
[0005] In such a technical flow, the present inventors have established a hair-growth drug assay method capable of simply and accurately assaying the above-described effect of extending the hair growth period. Therefore, the problem to be solved by the present invention is that a hair growth-increasing effect can be synergistically exhibited by combining the above-mentioned hair growth-prolonging effect in the hair-growth-testing method and the like with an active ingredient in combination with the active ingredient. An object of the present invention is to provide a hair restorer.

【0006】[0006]

【課題を解決するための手段】さらに本発明者は、この
課題の解決に向けて鋭意検討を行った結果、上記の育毛
薬剤検定方法で上記の毛髪成長期延長効果が認められ
る成分と上記のテストステロン−5α−レダクターゼ
阻害効果が認められる成分を組み合わせて有効成分とす
る育毛剤を提供することにより、この課題を解決し得る
ことを見出した。
Means for Solving the Problems Further, the present inventors have conducted intensive studies to solve this problem, and as a result, the above-mentioned hair growth stimulating method has the above-mentioned components which have the above-mentioned effect of extending the hair growth period and the above-mentioned components. It has been found that this problem can be solved by providing a hair restorer as an active ingredient by combining a component having a testosterone-5α-reductase inhibitory effect.

【0007】すなわち、本発明者は本願において以下の
発明を提供する。請求項1において、テストステロン−
5α−レダクターゼを阻害する作用を有する成分及び毛
周期における成長期を維持若しくは延長する作用を有す
る成分を有効成分とする育毛剤を提供する。
That is, the present inventor provides the following invention in the present application. The testosterone according to claim 1,
Provided is a hair restorer comprising, as an active ingredient, a component having an action of inhibiting 5α-reductase and a component having an action of maintaining or prolonging the anagen phase in the hair cycle.

【0008】請求項2において、毛周期における成長期
を維持若しくは延長する作用を有する成分が、毛包上皮
系細胞を増殖させる活性を有する成分である、前記請求
項1記載の育毛剤を提供する。
[0008] In the second aspect, the hair restorer according to the first aspect, wherein the component having an action of maintaining or prolonging the anagen phase in the hair cycle is a component having an activity of expanding hair follicle epithelial cells. .

【0009】請求項3において、毛包上皮系細胞を増殖
させる活性を有する成分が、コンフリー抽出物,ウコン
抽出物,タイソウ抽出物,コリアンダー抽出物,チョウ
センアサガオ抽出物,サイシン抽出物,ヨクイニン抽出
物,ステビア抽出物,アセンヤク抽出物,ゲンチアナ抽
出物,ホップ抽出物,ヒキオコシ抽出物,アズキ抽出
物,アルニカ抽出物,ハッカ抽出物,カンゾウ抽出物,
ブクリョウ抽出物,ダイズ抽出物,シソ抽出物,キナ抽
出物,スギナ抽出物,アンズ核粒抽出物,サンザシ抽出
物,センキュウ抽出物,ケイヒ抽出物,レイシ抽出物,
チョウジ抽出物,トウヒ抽出物及びローヤルゼリーから
なる群の成分から選ばれる1種又は2種以上の成分であ
る、前記請求項2記載の育毛剤。
[0009] In the third aspect, the component having an activity of growing hair follicle epithelial cells is a comfrey extract, a turmeric extract, a syrup extract, a coriander extract, a ginseng extract, a cycin extract, or a yoquinin extract. Extract, Stevia extract, Acacia extract, Gentian extract, Hop extract, Hioki sorghum extract, Azuki extract, Arnica extract, Mentha extract, Licorice extract,
Bakuryo extract, soybean extract, perilla extract, kina extract, horsetail extract, apricot kernel extract, hawthorn extract, senkyu extract, cinnamon extract, litchi extract,
The hair restorer according to claim 2, wherein the hair restorer is one or more components selected from the group consisting of a clove extract, a spruce extract and royal jelly.

【0010】[0010]

【発明の実施の形態】以下、本発明の実施の形態につい
て説明する。 A.本発明に関わる育毛剤(以下,本発明育毛剤とい
う)は、「毛周期における成長期を維持若しくは延長す
る作用を有する成分を有効成分とする育毛剤」である。
この毛周期における成長期を維持若しくは延長する作用
を有する成分(以下、成長期延長成分ともいう)は、こ
の作用により毛髪の伸長を促進することができる。
Embodiments of the present invention will be described below. A. The hair restorer according to the present invention (hereinafter referred to as the hair restorer of the present invention) is a "hair restorer comprising a component having an action of maintaining or prolonging the anagen phase in the hair cycle as an active ingredient".
A component having an action of maintaining or prolonging the anagen phase in the hair cycle (hereinafter, also referred to as a anagen component) can promote hair elongation by this action.

【0011】この成長期延長成分としては、例えばコン
フリー〔別名ヒレハリソウ(Symphytum Officinale L.)
ともいい,ヨーロッパ原産の多年生の草木である。〕の
抽出物;ウコン(Curcuma domestica Valton)の抽出物
(通常は根から抽出);タイソウ〔ナツメ(Zizyphus ju
jube Miller Var.inermis Rehder) 又はその近縁植物の
果実〕の抽出物;コエンドロ属に属する植物〔例えば,
コリアンダー サチバム(Coriandrum sativum L.)
等〕の抽出物(通常は,全草若しくは未熟果実から抽
出)〔以下,コリアンダー抽出物という〕;チョウセン
アサガオ属に属する植物〔例えば,シロバナチョウセン
アサガオ( Datura stramonium L.),ヨウシュチョウセ
ンアサガオ( Datura stramonium L. var. chalybea Ko
ch) 等〕の抽出物(通常,葉若しくは種子から抽出)
〔以下,チョウセンアサガオ抽出物という〕;サイシン
〔ウスバサイシン(Asarum sieboldii Miq.)又はこれの
変種若しくは亜種〕の抽出物(通常は,根部又は根茎部
から抽出);ヨクイニン〔ハトムギ(Coix lachryma-job
i L. var. ma-yuen Stapf)の果実からほうしょうと果
皮, 種皮を除いたもの〕の抽出物;ステビア(Stevia re
bandiana Bertoni) の抽出物(通常,地上部から抽
出);アセンヤク(Uncaria gambir Roxburgh) の抽出物
(通常は,葉又は若枝から抽出);ゲンチアナ(リンド
ウ,Gentiana lutea L.)の抽出物(通常は,根又は根茎
から抽出);ホップ(Humulus luplus L.) の抽出物〔通
常は,雌花穂(球果)から抽出〕;ヒキオコシ〔ヤマハ
ッカ属に属するヒキオコシ(Isodon japonicus Hara)又
はこれの変種若しくは亜種〕の抽出物(通常は延命草と
呼ばれる葉から抽出);
[0011] As the growth period extending component, for example, Comfrey [also known as Symphytum Officinale L.]
It is a perennial plant native to Europe. Extract; turmeric (Curcuma domestica Valton) extract (usually extracted from roots); diatom (jujube (Zizyphus ju
jube Miller Var. inermis Rehder) or a related plant thereof; an extract of a plant belonging to the genus Cilantro [eg,
Coriandrum sativum L.
Extract (usually extracted from whole plants or immature fruits) [hereinafter referred to as coriander extract]; plants belonging to the genus Datura (eg, Datura stramonium L.), Datura stramonium L. var.chalybea Ko
ch) etc.) (usually extracted from leaves or seeds)
[Hereinafter referred to as Datura morning glory extract]; an extract of cycin ( Asarum sieboldii Miq. Or a variant or subspecies thereof) (usually extracted from the root or rhizome); Yokuinin [ Coix lachryma- job
. i L. var ma-yuen Stapf ) reward and pericarp from the fruit of the, extract minus the seed coat]; Stevia (Stevia re
bandiana Bertoni) (usually extracted from above-ground parts); Acacia (Uncaria gambir Roxburgh) extract (usually extracted from leaves or shoots); Gentian (gentian, Gentiana lutea L.) extract (usually Extract from hops (Humulus luplus L.) [usually extracted from female cotyledons (cones)]; Hioki-koi [ Hioki-koi ( Isodon japonicus Hara) belonging to the genus Yamanaka or a variant or sub-species thereof Seed] extract (usually extracted from leaves called life-prolonging grass);

【0012】アズキ(Azukia angularis Ohw1)の抽出物
(通常は,種子から抽出);アルニカ(Arnica montana
L.) の抽出物(通常は,花から抽出);カンゾウ(Glycy
rrhiza glabra L.等) の抽出物(通常は,根又は根茎か
ら抽出);ハッカ(Mentha arvensis L. 等) の抽出物;
ブクリョウの抽出物〔マツホド(Poria cocos Wolf)の通
例であり、外層をほとんどのぞいた菌核から抽出して得
られる抽出物〕;ダイズ(Glycine max Merril)の抽出物
(通常は,種子から抽出);シソ(Perilla frutescens
Britton var.acuta Kudo等)の抽出物(通常は,葉又は
枝先から抽出);キナ(Cinchona succirubra Pavon et
Klotzch 等の抽出物(通常は,樹皮から抽出);スギナ
(Equisetum arvenes L.)の抽出物(通常は,全草から抽
出);ホンアンズ(Prunus armeniaca L.等)の核(内果
皮)の乾燥粉砕物から抽出される植物抽出物(以下,ア
ンズ核粒抽出物という);サンザシ(Crataegus cuneata
Siebold et Zuccarini)の抽出物(通常,果実から抽
出);センキュウ(Cnidium Rhizome Makino)の抽出物
(通常,根茎から抽出);Cinnamoum cassia Blume又は
その近縁植物の樹皮から抽出されるケイヒ抽出物;マン
ネンタケ子実体から抽出されるレイシ抽出物;チョウジ
(Syzygium aromaticum Merrill et Perry)の抽出物(通
常,つぼみから抽出);ダイダイ(Citrus aurantium L.
subsp.amara Engl.)の成熟した果皮から蒸留して得られ
る精油であるトウヒ抽出物;ローヤルゼリー,サイクロ
スポリンA,レチノール等を挙げることができるが、こ
れらの成分に限定されるものではない。なお、これらの
成分を毛髪成長期延長成分として単独で本発明育毛剤に
配合することもできるが、2種以上を組み合わせて配合
することも可能である。
An extract of Azukia (Azukia angularis Ohw 1 ) (usually extracted from seeds); Arnica (Arnica montana )
L.) extract (usually extracted from flowers); Licorice (Glycy
rrhiza glabra L.) extract (usually extracted from roots or rhizomes); Mint extract (Mentha arvensis L. etc.);
Bulky extract (extract of poria cocos wolf, which is customary and is obtained by extracting the outer layer from most sclerotia ); soybean (Glycine max Merril) extract (usually extracted from seed) ; Perilla frutescens
Extract of Britton var. Acuta Kudo etc. (usually extracted from leaves or branches); kina (Cinchona succirubra Pavon et.
Extracts such as Klotzch (usually extracted from bark);
(Equisetum arvenes L.) extract (usually extracted from whole plant); plant extract (hereinafter apricot kernel grain) extracted from dried and ground material of nucleus (endocarp) of Hong apricot (Prunus armeniaca L. etc.) Extract); hawthorn (Crataegus cuneata )
Extract of Siebold et Zuccarini (usually extracted from fruits); extract of Cnidium (Cnidium Rhizome Makino) (usually extracted from rhizomes); cinnamon extract extracted from bark of Cinnamoum cassia Blume or its closely related plants; Ganoderma oleracea extract extracted from Ganoderma lucidum fruit body;
(Syzygium aromaticum Merrill et Perry) extract (usually extracted from buds); Daidai (Citrus aurantium L.
subsp.amara Engl.), a spruce extract which is an essential oil obtained by distillation from mature pericarp; royal jelly, cyclosporin A, retinol, and the like, but are not limited to these components. These components can be used alone as the hair growth period extending component in the hair restorer of the present invention, but they can also be used in combination of two or more.

【0013】上記の毛髪成長期延長成分であるか否かの
判断は、その判断方法自体が成長期延長作用を特定する
ために妥当なものである限り特に限定されず、例えばin
vi tro における特定法も,in vivo における特定法も
用いることができるが、その簡便性と有効性を考慮する
と、in vitro における特定法を用いることが好まし
い。
[0013] whether a anagen extension component of the determination is not particularly limited as long as the determination method itself is reasonable to identify the growth-life extending effect, for example, in
Identification Method in vi tro also can be used, but a specific method in the in vivo, considering its simplicity and effectiveness, it is preferable to use a specific method of in vitro.

【0014】以下、このin vitro における特定法の一
つである、毛包系上皮培養細胞の増殖効果を検討するこ
とを特徴とする特定法について簡単に説明する(より具
体的には、実施例において記載する。)。
Hereinafter, one of the in vitro identification methods, which is characterized by examining the proliferation effect of hair follicle epithelial cultured cells, will be briefly described (more specifically, in Example 1). Described in.).

【0015】すなわちこの特定法は、「毛包上皮系培養
細胞に無血清培地中で対象物質を接触させて、その細胞
の増殖活性の有無及び/又は強弱を特定することによ
り、その対象物質の毛周期における成長期を維持若しく
は延長する効果を検定する育毛薬剤検定方法」、すなわ
ち毛髪の伸長に直接的に関係する毛包上皮系細胞に着目
し、この培養細胞を用いることによって、所望する毛周
期における成長期を維持若しくは延長する効果を特定す
る、in vitroの育毛薬剤検定方法である。
[0015] That is, this identification method is as follows: "A culture of hair follicle epithelial cells is brought into contact with a target substance in a serum-free medium, and the presence or absence and / or strength of the proliferation activity of the cell is specified. A hair growth-testing method for testing the effect of maintaining or prolonging the anagen phase in the hair cycle, that is, focusing on hair follicle epithelial cells directly related to hair elongation, and using the cultured cells to obtain desired hair This is an in vitro hair growth drug assay method for determining the effect of maintaining or prolonging the growth phase in a cycle.

【0016】この育毛薬剤検定方法においては、動物
(ヒトを含む,以下同様である)の毛包上皮系細胞を単
離して得た培養細胞である「毛包上皮系培養細胞」に対
象物質を接触させて、その増殖の有無及び/又は強弱を
特定する。毛包上皮系細胞は、特に毛根近傍の外毛根鞘
細胞とマトリクス細胞とを併せた部分の細胞のことを指
し、内側の毛乳頭細胞とそれを覆う基底膜部分は除外さ
れる。毛根の根幹部分に位置する毛乳頭細胞は、この毛
包上皮系細胞に働きかけてその増殖を促すことで毛の伸
長を促進する。
In this method for assaying a hair-growth agent, the target substance is added to a "hair follicle epithelial cell culture" which is a cultured cell obtained by isolating hair follicle epithelial cells of animals (including humans, the same applies hereinafter). By contact, the presence or absence and / or strength of the proliferation is specified. The hair follicle epithelial cell refers to a cell in which the outer root sheath cell and the matrix cell in the vicinity of the hair root are combined, and the inner hair papilla cell and the basement membrane covering the cell are excluded. Hair papilla cells located at the root of the hair root act on these hair follicle epithelial cells to promote their proliferation, thereby promoting hair elongation.

【0017】毛周期における成長期は、まさにこの毛髪
が伸長している時期,すなわち毛包上皮細胞が分裂して
増殖している時期であり、同退行期及び休止期は、これ
が鈍化して休止する時期である。つまり、毛周期におけ
る成長期を維持若しくは延長させる物質は、その投与に
より毛包上皮系細胞の分裂及び増殖活性を維持すること
によって、毛髪が毛周期における退行期及び休止期への
移行を防ぐ物質、すなわち毛包上皮系細胞の増殖を促進
又は維持し続ける物質であることが結論付けられる。
The anagen in the hair cycle is the period when the hair is elongating, that is, the period when the hair follicle epithelial cells are dividing and proliferating. It is time to do it. In other words, the substance that maintains or prolongs the anagen phase in the hair cycle is a substance that prevents the hair from entering the catagen and telogen phases of the hair cycle by maintaining the division and proliferation activity of hair follicle epithelial cells by its administration. That is, it is concluded that the substance is a substance that continues to promote or maintain the proliferation of hair follicle epithelial cells.

【0018】なお、その他のin vitroの育毛薬剤検定方
法として、例えば対象物質を動物の毛乳頭細肪に作用さ
せて、その増殖促進効果を判定する方法等を挙げること
ができる。
As another in vitro method for assaying a hair growth drug in vitro , for example, a method in which a target substance is allowed to act on the dermal papilla fat of an animal to determine its growth promoting effect, etc.

【0019】また、in vivo における判断方法として
は、例えば「ヌードマウスに対象物質を投与し,このヌ
ードマウスの体表の発毛部位の状態を特定して,対象物
質の毛周期における成長期を維持若しくは延長する効果
を検定する育毛薬剤検定方法」、すなわち原則的には無
毛であるが、その体表に経時的にその発毛部位が移動す
る特徴的な発毛をするヌードマウスにおける発毛部位の
広さと発毛部位の移動速度を特定することによって、毛
周期における成長期の長さを検定する方法等を挙げるこ
とができる。
As a method of in vivo determination, for example, “a target substance is administered to a nude mouse, the state of the hair growth site on the body surface of the nude mouse is specified, and the growth period of the target substance in the hair cycle is determined. A hair growth drug assay method for assessing the effect of maintaining or prolonging hair growth, i.e., hair growth in nude mice that are hairless in principle, but whose hair growth site moves to the body surface over time with characteristic hair growth. A method of testing the length of the anagen phase in the hair cycle by specifying the width of the hair site and the moving speed of the hair growth site can be mentioned.

【0020】B.また、本発明育毛剤は、前記の成分と
共に「テストステロン−5α−レダクターゼを阻害する
作用を有する成分」を有効成分とする育毛剤である。テ
ストステロン−5α−レダクターゼを阻害する作用を有
する成分(以下、5α−レダクターゼ阻害成分ともい
う)は、この作用により頭部における5α−レダクター
ゼの作用による脱毛を阻害することができる。
B. Further, the hair restorer of the present invention is a hair restorer containing, as an active ingredient, "a component having an action of inhibiting testosterone-5α-reductase" together with the above-mentioned components. A component having an effect of inhibiting testosterone-5α-reductase (hereinafter also referred to as a 5α-reductase inhibitory component) can inhibit hair loss by the action of 5α-reductase in the head by this effect.

【0021】この5α−レダクターゼ阻害成分として
は、例えばシャクヤク〔シャクヤク(Paeonia albiflora
Pall. var. trichocarpa Bunge)又はこれの変種若しく
は亜種〕の抽出物(全草から抽出可);ハッカ抽出物;
サンザシ抽出物;ジャンカン〔アオギリ科(Sterculiace
ae) に属するスタークリアフォエチダ(Sterculia foeti
da L.)等に由来し, その果皮を主な抽出対象とする〕の
抽出物;ウォロ〔ヤシ科(Palmae)に属するボラッサス
フラベリフェア(Borassus flabellifera L.)等に由来
し、その花を主な抽出対象とする〕の抽出物;ダウン・
トラウズ〔クスノキ科(Lauraceae)に属するリッツアエ
オドリフェラ(Litsea odorifera Val.) 等に由来し,
その果実を主な抽出対象とする〕の抽出物;コリアンダ
ー抽出物等を挙げることができる。
As the 5α-reductase inhibitory component, for example, a peony [ Paeonia albiflora
Trichocarpa Bunge) or a variant or subspecies thereof (extractable from whole plant); mint extract;
Hawthorn extract; Jancan [ Sterculiaceae (Sterculiaceae)
ae ) belonging to the star clear foeti (Sterculia foeti
da L.), etc., and its pericarp is the main object of extraction]; Woro (Bolassus belonging to the family Palmae)
Flaverifare (Borassus flabellifera L.) and its flowers are the main target of extraction]
Torauzu [Lauraceae (Lauraceae) belonging to Rittsuae Odorifera (Litsea odorifera Val.) Derived from, etc.,
Extracts of which are the main extraction targets]; coriander extract and the like.

【0022】また、モモ抽出物,キンミジヒキ抽出物,
ボケ抽出物,クサボケ抽出物,オンボツ抽出物,ヒワ抽
出物,ヤマザクラ抽出物,ヘビイチゴ抽出物,オランダ
イチゴ抽出物,ボンンティラ抽出物,トルメンチラ抽出
物,アーモンド抽出物,アンズ抽出物,トウニン抽出
物,オウヒ抽出物,ウメ抽出物,ユスラウメ抽出物,ダ
イコンソウ抽出物,バクチクノキ抽出物,テリハイバラ
抽出物,ナナカマド抽出物,セイヨウバラ抽出物,キイ
チゴ抽出物,トックリイチゴ抽出物,シマバライチゴ抽
出物,エビガライチゴ抽出物,ワレモコウ抽出物,シモ
ツケ抽出物,チシマザクラ抽出物,フユイチゴ抽出物,
フクボン抽出物,カリン抽出物,カシ抽出物,テンモン
ドウ抽出物,バクモンドウ抽出物,エンゴサク抽出物,
コウブシ抽出物,コロンボ抽出物,コンズランゴ抽出
物,サンシュユ抽出物,サンズコン抽出物,サンシチソ
ウ抽出物,セイヨウノコギリソウ抽出物,トコン抽出
物,ミツガシワ抽出物,セレノア抽出物,アセンヤク抽
出物,ウイキョウ抽出物,オンジ抽出物,カンゾウ抽出
物,ケンゴシ抽出物,ゴバイシ抽出物,シャクヤク抽出
物,シャゼンシ抽出物,センソ抽出物,ダイオウ抽出
物,チョウジ抽出物,ビンロウジ抽出物,ロジン抽出
物,カッコウアザミ抽出物,ゲンノショウコ抽出物,カ
ゴソウ抽出物,サイコ抽出物,インチン抽出物,エイジ
ツ抽出物,ヨクイニン抽出物,ソヨウ抽出物,ニガキ抽
出物,
In addition, peach extract, goldfish extract,
Bokeh extract, Laceae extract, Ombo extract, Hikawa extract, Yamazakura extract, Snake strawberry extract, Dutch strawberry extract, Bonuntilla extract, Tormentilla extract, Almond extract, Apricot extract, Tonin extract, Spruce Extract, plum extract, capsicum extract, Japanese radish extract, black bean extract, terry high rose extract, rowan extract, Atlantic rose extract, raspberry extract, tokli strawberry extract, simabarai strawberry extract, shrimp strawberry extract , Waremokou extract, Spiraea extract, Chishima cherry extract, strawberry extract,
Fukubon extract, Karin extract, Oak extract, Tenmondou extract, Bakumondou extract, Engosaku extract,
Kobushi extract, Colombo extract, Konzulango extract, Sanshuyu extract, Sanzukon extract, Paniculata extract, Achillea millefolium extract, Tokonomi extract, Honeysuckle extract, Selenoa extract, Acacia extract, Fennel extract, Onji Extract, licorice extract, cinnamon extract, goby extract, peonies extract, shazens extract, senso extract, rhubarb extract, clove extract, areca extract, rosin extract, cuckoo thistle extract, gennoshoko extract , Sprouts extract, psycho extract, intin extract, oedum extract, yokuinin extract, soybean extract, nigaki extract,

【0023】ケイガイ抽出物,キササゲ抽出物,ジョウ
ザン抽出物,カノコソウ抽出物,ウスベニアオイ抽出
物,ヤクモソウ抽出物,ゴボウシ抽出物,サイカチ抽出
物,サンシシ抽出物,キンモクセイ抽出物,セドロン抽
出物,イエルバルイサ抽出物,アチコリア抽出物,マチ
コ抽出物,カルドサント抽出物,オルティガニグラ抽出
物,チャンカビエドラ抽出物,華古茶の葉若しくは茎の
抽出物,ワタの種子の抽出物,イチイの葉若しくは樹皮
の抽出物,ガラナの種子の抽出物,エピカキテン,エピ
ガロカキテン,エピガロコテキンガレード,グリチルレ
チン酸,シノール,シノール類似体、特定の不飽和脂肪
酸(リノール酸,ペトロセリン酸)等の不飽和脂肪酸等
を例示可能であるが、これらの成分に限定されるもので
はない。なお、これらの成分をα−レダクターゼ阻害成
分として単独で本発明育毛剤に配合することもできる
が、2種以上を組み合わせて配合することも可能であ
る。
Extracts of oyster scallop, catalpa extract, japonicus extract, valerian extract, velvet extract, primrose extract, burdock extract, honey locust extract, sanshishi extract, primrose extract, sedron extract, yerbarisa extract , Achicoria extract, Machiko extract, Cardosant extract, Ortiganigra extract, Chancabiedra extract, Chinese tea leaf or stem extract, Cotton seed extract, Taxus leaf or bark extract , Guarana seed extract, epicaquitene, epigallocaquiten, epigallocotechin galade, glycyrrhetinic acid, sinol, sinol analogues, unsaturated fatty acids such as specific unsaturated fatty acids (linoleic acid, petroselinic acid), etc. However, it is not limited to these components. These components can be used alone as the α-reductase inhibiting component in the hair restorer of the present invention, but they can also be used in combination of two or more.

【0024】上記のα−レダクターゼ阻害成分であるか
否かの判断は、その判断方法自体が5α−レダクターゼ
の阻害作用を特定するために妥当なものである限り特に
限定されない。例えば、テストステロンから,いわゆる
作用型アンドロゲンと称される5α−ジヒドロテストス
テロンへの変換に関与する,テストステロン−5α−レ
ダクターゼに対する阻害活性をin vitroで特定する方法
等を例示することができる。
The determination as to whether or not the component is an α-reductase inhibitor is not particularly limited as long as the determination method itself is appropriate for specifying the inhibitory effect of 5α-reductase. For example, there can be exemplified a method for identifying in vitro an inhibitory activity on testosterone-5α-reductase, which is involved in the conversion of testosterone into 5α-dihydrotestosterone, which is called a so-called action androgen.

【0025】上記の諸成分のうち植物由来の抽出物を抽
出する際には、植物由来の抽出物を抽出する際に一般的
に用いられる方法で行うことができる。すなわち、前記
した植物を、生のまま,又は必要により乾燥した後、そ
のまま若しくは粉砕して溶媒抽出に供することにより得
ることができる。この際用い得る溶媒は、植物からその
植物の成分を抽出する際に用いられる一般的な溶媒を用
いることが可能であり特に限定されず、例えば熱水;メ
タノール,エタノール,イソプロパノール,n−ブタノ
ール等の低級アルコール;プロピレングリコール、1,
3−ブチレングリコール等の多価アルコール;これらの
アルコール類の含水物;n−ヘキサン,トルエン等の炭
化水素系溶媒等を挙げることができるが、メタノールや
エタノール等の低級アルコールを抽出溶媒として用いる
のが好ましい。これらの低級アルコールを抽出溶媒とし
て用いる場合、得られる抽出液をそのまま本発明毛髪成
長期延長剤の有効成分として配合することができるが、
抽出溶媒を一旦留去し,必要により乾燥後に配合するこ
とも可能である。また、本発明育毛剤においては、前記
諸成分の市販品をも用いることができることは勿論であ
る。
Extraction of a plant-derived extract from the above components can be carried out by a method generally used for extracting a plant-derived extract. That is, it can be obtained by subjecting the above-mentioned plant as it is or after drying it as necessary, and then subjecting it to solvent extraction as it is or pulverized. As a solvent that can be used at this time, a common solvent used when extracting a component of the plant from the plant can be used and is not particularly limited. Examples thereof include hot water; methanol, ethanol, isopropanol, and n-butanol. Lower alcohols; propylene glycol, 1,
Polyhydric alcohols such as 3-butylene glycol; hydrates of these alcohols; hydrocarbon solvents such as n-hexane and toluene; and lower alcohols such as methanol and ethanol as extraction solvents. Is preferred. When these lower alcohols are used as the extraction solvent, the resulting extract can be directly blended as an active ingredient of the hair growth period extender of the present invention,
It is also possible to once remove the extraction solvent and mix it after drying if necessary. In the hair restorer of the present invention, it is a matter of course that commercially available products of the above-mentioned various components can be used.

【0026】本発明育毛剤における上記諸成分の配合量
(成長期延長成分及び5α−レダクターゼ阻害成分の配
合量の和)は、本発明育毛剤の具体的形態等に応じて適
宜選択し得るものであり、特に限定されるべきものでは
ないが、概ね本剤全体に対して乾燥物として0.000
05重量%以上,20.0重量%以下、好ましくは同
0.01重量%以上,10.0重量%以下となるように
配合される。
The amounts of the above components (the sum of the amounts of the growth-prolonging component and the 5α-reductase inhibitor) in the hair restorer of the present invention can be appropriately selected according to the specific form of the hair restorer of the present invention. Although it is not particularly limited, it is generally 0.000 as a dry matter with respect to the whole of the present drug.
It is blended so as to be at least 05% by weight and at most 20.0% by weight, preferably at least 0.01% by weight and at most 10.0% by weight.

【0027】本剤全体に対して乾燥物として0.000
05重量%未満の配合量では、本発明の所期の効果であ
る毛包系細胞増殖作用に基づく育毛効果が十分に発揮さ
れず好ましくなく、同20.0重量%を超えて配合して
も、配合量の増加に見合った効果の増大を見込めないば
かりではなく、製剤上支障をきたす傾向が顕著となり好
ましくない。
[0027] 0.000 as a dry matter with respect to the whole agent
If the amount is less than 05% by weight, the desired effect of the present invention, the hair growth effect based on the hair follicle cell proliferation effect, is not sufficiently exhibited, which is not preferable. In addition, not only is it not possible to expect an increase in the effect corresponding to the increase in the amount of the compound, but also the tendency to cause troubles in the preparation becomes remarkable, which is not preferable.

【0028】また、成長期延長成分と5α−レダクター
ゼ阻害成分との配合割合は、本発明育毛剤の具体的形態
や具体的に選択する成分に応じて適宜選択するべきもの
であり、特に限定されるべきものではないが、概ね等量
で配合することが好ましい。この配合割合から逸脱する
範囲で、上記諸成分を本発明育毛剤中に配合すると、片
方の作用が強くなりすぎ、所望する相異なる作用を有す
る成分を組み合わせて配合することによる、相乗的な育
毛効果が発揮されなくなる傾向にあり好ましくない。
The mixing ratio of the growth-prolonging component and the 5α-reductase-inhibiting component is to be appropriately selected according to the specific form of the hair restorer of the present invention and specifically selected components, and is not particularly limited. Although not necessary, it is preferable to mix them in approximately equal amounts. When the above components are blended in the hair growth agent of the present invention within a range deviating from this blending ratio, the action of one of them becomes too strong, and the synergistic hair growth is achieved by combining and combining components having desired different actions. The effect tends to stop being exhibited, which is not preferable.

【0029】このように本発明育毛剤は、上記の成長期
延長成分及び5α−レダクターゼ阻害成分を有効成分と
する育毛剤であり、優れた毛包上皮系細胞増殖活性化
作用等に基づく毛髪成長期延長促進作用と5α−レダ
クターゼ阻害作用による脱毛防止作用とを有し、これら
両者の成分が毛髪に対して相乗的に働くことにより、す
なわち毛包上皮系細胞の増殖活性が維持されて成長期が
延長すると共に,毛髪の頭皮における定着率が向上する
ことにより、非常に優れた育毛作用を発揮する。
As described above, the hair restorer of the present invention is a hair restorer containing the above-mentioned growth period extending component and 5α-reductase inhibitory component as active ingredients, and has an excellent hair growth epithelial cell proliferation activating action and the like. It has a prolongation promoting action and a hair loss preventing action by inhibiting 5α-reductase, and these two components act synergistically on hair, that is, the proliferation activity of hair follicle epithelial cells is maintained, As a result, the hair growth effect is extremely improved by improving the hair fixation rate on the scalp.

【0030】本発明育毛剤は、例えば相対的に成長期毛
よりも休止期毛の割合が多くなってしまうことに起因す
る脱毛症や、5α−レダクターゼが過度に亢進すること
による脱毛症に対して特に有効な薬剤である。また、他
の個別効能を有する育毛料と組み合わせて用いることに
より、他の脱毛症において相乗的な効果を上げることも
また可能である。
The hair restorer of the present invention can be used, for example, for alopecia caused by relatively higher proportion of telogen hair than anagen hair or alopecia caused by excessively increased 5α-reductase. It is a particularly effective drug. It is also possible to achieve a synergistic effect in other alopecia by using it in combination with other hair restorers having individual effects.

【0031】本発明育毛剤が採り得る剤型は、外皮に適
用可能な剤型であれば特に限定されず、例えば液状,乳
液,軟膏等を選択可能である。また、本発明育毛剤の形
態は任意であり、例えばトニック,ヘアークリーム,ム
ース,シャンプー,リンス,クリーム,乳液,化粧水,
パック等の形態を採ることができる。
The dosage form that the hair growth agent of the present invention can take is not particularly limited as long as it is a dosage form applicable to the outer skin, and for example, liquid, emulsion, ointment and the like can be selected. Further, the form of the hair restorer of the present invention is arbitrary, and for example, tonic, hair cream, mousse, shampoo, rinse, cream, emulsion, lotion,
It can take the form of a pack or the like.

【0032】本発明育毛剤においては、前記の必須成分
に加えて必要に応じて、かつ本発明の所期の効果を損な
わない限りにおいて、化粧品,医薬部外品,医薬品等に
おいて一般的に用いられる各種油性若しくは水性成分,
保湿剤,増粘剤,防腐剤,酸化防止剤,香料,色剤,各
種薬剤等を配合することができる。
The hair restorer of the present invention is generally used in cosmetics, quasi-drugs, pharmaceuticals, etc., in addition to the above essential components, if necessary and as long as the intended effect of the present invention is not impaired. Various oily or aqueous components,
A humectant, a thickener, a preservative, an antioxidant, a fragrance, a coloring agent, various chemicals and the like can be added.

【0033】例えば、高級脂肪酸,固形パラフィン,流
動パラフィン,シリコーン油,スクワラン,モノオレイ
ン酸グリセリル,オリーブ油,イソプロピルミリステー
ト,高級脂肪酸,高級アルコール等の油分;グリセリ
ン,ヒアルロン酸,プロピレングリコール,マルチトー
ル,アテロコラーゲン,乳酸ナトリウム等の保湿剤;マ
ルメロ粘質物,カルボキシビニルポリマー,キサンタン
ガム等の増粘剤;ニコチン酸アミド,ニコチン酸ベンジ
ル,ビタミンEアセテート,センブリ抽出物,塩化カル
プロニウム,アセチルコリン誘導体等の血管拡張剤;セ
リン,メチオニン,アルギニン等のアミノ酸類;ビタミ
ンB6 ,ビタミンE(若しくはその誘導体),ビオチ
ン,パントテン酸(若しくはその誘導体)等のビタミン
類;ニコチン酸,ニコチン酸メチル,ニコチン酸トコフ
ェロール等のニコチン酸エステル類;セファランチン等
の皮膚機能亢進剤;エストラジオール等の女性ホルモン
剤;グリチルレチン酸(若しくはその誘導体)等の消炎
剤;ヒノキチオール,ヘキサクロロフェン,ベンザルコ
ニウムクロリド,ビチオノール等の抗菌剤;メントール
等の清涼剤;サリチル酸,亜鉛(若しくはその誘導
体),乳酸(若しくはそのアルキルエステル)等;クエ
ン酸等の有機酸類等を配合することができる。本発明育
毛剤の具体的処方は後述する。
For example, higher fatty acids, solid paraffin, liquid paraffin, silicone oil, squalane, glyceryl monooleate, olive oil, isopropyl myristate, higher fatty acids, higher alcohols and other oils; glycerin, hyaluronic acid, propylene glycol, maltitol, Moisturizing agents such as atelocollagen and sodium lactate; thickeners such as quince, carboxyvinyl polymer and xanthan gum; vasodilators such as nicotinamide, benzyl nicotinate, vitamin E acetate, assembly extract, carpronium chloride and acetylcholine derivatives ; serine, methionine, amino acids such as arginine; vitamin B 6, vitamin E (or derivatives thereof), biotin, vitamins such as pantothenic acid (or derivatives thereof); nicotinic acid, Nico Nicotinic acid esters such as methyl phosphate and tocopherol nicotinate; skin function enhancers such as cepharanthin; female hormones such as estradiol; anti-inflammatory agents such as glycyrrhetinic acid (or a derivative thereof); hinokitiol, hexachlorophen, benzalkonium chloride Antibacterial agents such as thiol, bitionol, etc .; cooling agents such as menthol; salicylic acid, zinc (or a derivative thereof), lactic acid (or an alkyl ester thereof); and organic acids such as citric acid. Specific formulations of the hair restorer of the present invention will be described later.

【0034】[0034]

【実施例】以下、実施例等により本発明をさらに具体的
に説明するが、この実施例等により本発明の技術的範囲
が限定的に解釈されるべきものではない。なお、以下の
実施例等において「%」と表示され,かつ内容量を示す
ものは、特に断らない限り重量%を意味する。まず、対
象物質の毛髪成長期延長促進作用を評価するためのin v
itroの細胞増殖試験について説明する。
EXAMPLES Hereinafter, the present invention will be described more specifically with reference to Examples and the like, but the technical scope of the present invention should not be construed as being limited by these Examples and the like. In the following examples and the like, "%" and the content are indicated by weight unless otherwise specified. First, in v to evaluate the effect of the target substance on promoting hair growth
The cell proliferation test of itro will be described.

【0035】〔試験例1〕毛包上皮系培養細胞を用いた
細胞増殖試験 A.ヒト毛包上皮系細胞 1.ヒト毛包上皮系細胞の採取 外科手術の副産物として得られたヒト男性頭皮から毛周
期における成長期の毛包を実体顕微鏡下で機械的に採取
した。この成長期の毛包を1000 U/ml dispase・0.2 %
コラゲナーゼを含むダルベッコの改変MEM(DME
M)で30分間,37℃で処理し、注射針の先を用いて
dermal sheath やdermal papilla、毛球部上皮組織を除
去して、0.05%トリプシン・0.02%EDTAを含むリン
酸緩衝液〔PBS(−):(−)とはカルシウムイオン
やマグネシウムイオンを含まない意味である〕で5分
間,37℃で処理した。次にコラーゲン(Type I)コー
ティングした培養皿に毛包を静置し、外殖片培養を行っ
た。なおこの際の培地は、無血清培地〔Keratinocyte G
rowth Medium(KGM)〕を用いた(Keratinocyte Ser
um Free Mediumを用いることもできる)。
Test Example 1 Cell Proliferation Test Using Hair Follicle Epithelial Cultured Cells Human hair follicle epithelial cells 1. Collection of Human Hair Follicle Epithelial Cells Hair follicles during the anagen phase of the hair cycle were mechanically collected from a human male scalp obtained as a by-product of surgery under a stereoscopic microscope. 1000 U / ml dispase 0.2%
Dulbecco's modified MEM containing collagenase (DME
M) for 30 minutes at 37 ° C., using the tip of a syringe needle.
Phosphate buffer solution containing 0.05% trypsin and 0.02% EDTA after removing dermal sheath, dermal papilla and epithelium of hair bulb [PBS (-): (-) means that it does not contain calcium or magnesium ions Yes] for 5 minutes at 37 ° C. Next, the hair follicle was allowed to stand on a culture dish coated with collagen (Type I), and explant culture was performed. In this case, the medium was a serum-free medium [Keratinocyte G
rowth Medium (KGM)] (Keratinocyte Ser
um Free Medium can also be used).

【0036】この培養の4〜5日後に、毛包の培養皿へ
の接着及び細胞の増殖が確認できた時点で培地を交換
し、これ以降2日おきに培地交換を行った。このように
して増殖させた細胞を、0.05wt%トリプシン-0.02 %E
DTAで37℃で5分間処理した後、等量の0.1 %トリ
プシンインヒビターで反応を停止させ、遠心処理(800×
g,5 分間) を施して細胞を回収した。次に、細胞を上記
の無血清培地に浮遊させて、5000 cells/cm2の密度でコ
ラーゲンコーティング(Type I)した培養皿に播種し、
細胞がsubconfluentになるまで2日おきに培地交換を行
い、再び0.05wt%トリプシン-0.02 %EDTAで37℃
で5分間処理した後、等量の0.1 %トリプシンインヒビ
ターで反応を停止させ、遠心処理(800×g,5 分間) を施
して、これにより得られたヒト毛包上皮系細胞に細胞凍
結液(セルバンカー:ダイヤトロン製)を添加し、1.
0×106 cell/ml の濃度に調整して、各凍結チューブ
に1.0×106 cellずつ入れ、これを凍結保存した。
なお、これらの細胞数は、血球算定板で算出した。
After 4 to 5 days of this culture, when the attachment of the hair follicle to the culture dish and the growth of the cells were confirmed, the medium was changed, and thereafter the medium was changed every two days. The cells grown in this manner were transformed with 0.05 wt% trypsin-0.02% E
After treatment with DTA at 37 ° C. for 5 minutes, the reaction was stopped with an equal volume of 0.1% trypsin inhibitor, and centrifuged (800 ×
g, for 5 minutes) to collect the cells. Next, the cells were suspended in the above serum-free medium, and seeded on a collagen-coated (Type I) culture dish at a density of 5000 cells / cm 2 ,
The medium was changed every two days until the cells became subconfluent, and again with 0.05 wt% trypsin-0.02% EDTA at 37 ° C.
After 5 minutes, the reaction was stopped with an equal volume of 0.1% trypsin inhibitor, centrifuged (800 × g, 5 minutes), and the resulting human hair follicle epithelial cells were subjected to cell freeze-up ( Cell Banker: manufactured by Diatron).
The concentration was adjusted to 0 × 10 6 cells / ml, and 1.0 × 10 6 cells were added to each cryotube, and the cells were cryopreserved.
In addition, these cell numbers were calculated with a blood cell counting plate.

【0037】2.対象物質のアッセイ 上記工程により得た毛包上皮系細胞の線維芽細胞混入率
(FB混入率)を測定(3000倍,5視野)し、その
結果FB混入率が3%以上のものは、アッセイの対象か
ら除外した。そして、この毛包上皮系細胞を培養フラス
コ中に播種後、これを0.05%トリプシンと0.02
%EDTAで処理した後、0.1%トリプシンインヒビ
ターで反応を停止後、系を1500rpm で5分間遠心処
理を施し、上清を除去し、残渣にKGM培地20mlを添
加して、細胞懸濁液を調製した。
2. Assay of target substance The fibroblast contamination rate (FB contamination rate) of the hair follicle epithelial cells obtained by the above steps was measured (3000 times, 5 visual fields). As a result, if the FB contamination rate was 3% or more, the assay was performed. Was excluded from the target. Then, after inoculating the hair follicle epithelial cells in a culture flask, the cells were mixed with 0.05% trypsin and 0.02%.
After treatment with% EDTA, the reaction was stopped with 0.1% trypsin inhibitor, the system was centrifuged at 1500 rpm for 5 minutes, the supernatant was removed, 20 ml of KGM medium was added to the residue, and the cell suspension was removed. Was prepared.

【0038】0.2ml/well の割合で、96well-plate
(I型コラーゲンコーティングプレート:ファルコン社
製)に播種し(1.0×104cell/well)、細胞がウエ
ルの底に沈むまで約20分間室温下で放置した。その
後、37℃,5%CO2 で1日間培養を行い、所望する
ヒト毛包上皮系培養細胞を得た。
96 well-plate at a rate of 0.2 ml / well
(Type I collagen coated plate: manufactured by Falcon) (1.0 × 10 4 cells / well), and allowed to stand at room temperature for about 20 minutes until the cells sank to the bottom of the well. Thereafter, the cells were cultured for 1 day at 37 ° C. and 5% CO 2 to obtain desired human hair follicle epithelial cultured cells.

【0039】B.ラット毛包上皮系細胞 1.ラット毛包上皮系細胞の採取: (1)毛包の採取 新生児(3〜4日令)のラットをエタノールで消毒後、
二酸化炭素で屠殺し、これらのラットの背部皮膚をハサ
ミで採取した。次いで、この採取した背部皮膚を1%P
SF含有PBS(−)に2枚ずつ浸した。その後、皮膚
脂肪層から下の皮下脂肪や皮膜等を解剖用ハサミで除去
した。 次いで、再びこの背部皮膚を1%PSF含有P
BS(−)に浸し、さらにこれを0.25%トリプシン
含有PBS(−)(0.02%EDTA含む。以下、同
様である。)中に4℃で一晩浸した。
B. Rat hair follicle epithelial cells 1. Collection of rat hair follicle epithelial cells: (1) Collection of hair follicles After disinfecting neonatal (3-4 day old) rats with ethanol,
The rats were sacrificed with carbon dioxide and the back skin of these rats was collected with scissors. Then, the collected back skin was added with 1% P
Two sheets were immersed in SF-containing PBS (-) at a time. Thereafter, the subcutaneous fat, skin, and the like below the skin fat layer were removed with scissors for dissection. Then, the back skin was again cleaned with P containing 1% PSF.
This was immersed in BS (-), and further immersed in PBS (-) containing 0.25% trypsin (containing 0.02% EDTA; the same applies hereinafter) at 4 ° C overnight.

【0040】このトリプシン溶液中における浸漬後、背
部皮膚の真皮層と表皮層をピンセットで剥がした後、真
皮層を0.35%のコラゲナーゼを含有させたHam'
sF12培地〔組成(mg/L):l-Alanin(8.9),l-Arginine
(HCl:211),l-Asparagine(13.2),l-Asparatic acid(13.
3),l-Cysteine (HCl:31.5),l-Glutamic acid(14.7),l-
Glutamine(146),Glycine(7.5),l-Histidine (HCl:19),
l-Isoleucine(3.9),l-leucine(13.1),l-Lysine(HCl:36.
5),l-Methionine(4.5),l-Phenylalanin(5.0),Proline(3
4.5),l-Serine(10.5),l-Threonine(11.9),l-Tryptophan
e(2.0),l-Tyrosine(5.4),l-Valine(11.7),Biotine(0.00
73),Choline(Cl:14.0),VitaminB12(1.36),葉酸(1.32),I
nositol(18.0),Nicotinamide(0.037),パントテン酸(Ca:
0.477),VitaminB6(HCl:0.062),VitaminB2(0.038),Vitam
inB1(HCl:0.337),CaCl2(2H2O:44.0),CuSO4・5H2O(0.002
5),FeSO4・7H2O(0.834),KCl(224.0),MgCl2(6H2O:122),
"Proc.Natl.Acad.Sci.USA,53,288(1965)" 以下同様であ
る〕が入った100 mm dish 移し、ハサミで裁断した。こ
の裁断物を含む培地を37℃で35分間浸透を行った
(60rpm )。浸透後、このコラゲナーゼ反応物中に塊
状のものが見えなくなるまでピペッティングを行い、こ
れを50ml遠沈管に移し、DNase (10000unit) を含
有させたHam's F12培地を添加し、5分間放置し
た。
After immersion in this trypsin solution, the dermis layer and epidermis layer of the back skin were peeled off with tweezers, and the dermis layer was replaced with Ham 'containing 0.35% collagenase.
sF12 medium [composition (mg / L): l-Alanin (8.9), l-Arginine
(HCl: 211), l-Asparagine (13.2), l-Asparatic acid (13.
3), l-Cysteine (HCl: 31.5), l-Glutamic acid (14.7), l-
Glutamine (146), Glycine (7.5), l-Histidine (HCl: 19),
l-Isoleucine (3.9), l-leucine (13.1), l-Lysine (HCl: 36.
5), l-Methionine (4.5), l-Phenylalanin (5.0), Proline (3
4.5), l-Serine (10.5), l-Threonine (11.9), l-Tryptophan
e (2.0), l-Tyrosine (5.4), l-Valine (11.7), Biotine (0.00
73), Choline (Cl: 14.0), Vitamin B12 (1.36), folic acid (1.32), I
nositol (18.0), Nicotinamide (0.037), pantothenic acid (Ca:
0.477), VitaminB6 (HCl: 0.062), VitaminB2 (0.038), Vitam
inB1 (HCl: 0.337), CaCl 2 (2H 2 O: 44.0), CuSO 4・ 5H 2 O (0.002
5), FeSO 4 · 7H 2 O (0.834), KCl (224.0), MgCl 2 (6H 2 O: 122),
Acad. Sci. USA, 53,288 (1965) "). A 100 mm dish containing the same was transferred and cut with scissors. The medium containing the cut product was permeated at 37 ° C. for 35 minutes (60 rpm). After infiltration, pipetting was carried out until no clumps could be seen in the collagenase reaction product, and this was transferred to a 50 ml centrifuge tube, Ham's F12 medium containing DNase (10000 units) was added, and the mixture was allowed to stand for 5 minutes. .

【0041】放置後、得られた懸濁液をさらにピペッテ
ィングした後、ナイロンメッシュ(Nytex 157 mesh) で
濾過し、これを50ml遠沈管に移した。懸濁液を半量ず
つに分け、それぞれについてPBS(−)を容量が30
mlになるまで懸濁液を希釈し、次いでこの希釈した懸濁
液に遠心処理を施した(4℃,400rpm ,5分間)。
遠心後、上清を除いて脂肪分を系から除去した。次い
で、残渣にPBS(−)を25ml添加して懸濁後、これ
にさらに遠心処理を施した〔(4℃,400rpm ,5分
間)×3回〕。この遠心操作により得られた残渣が、ラ
ットの背部皮膚における毛包である。
After standing, the resulting suspension was further pipetted, filtered through a nylon mesh (Nytex 157 mesh), and transferred to a 50 ml centrifuge tube. The suspension was divided into half volumes, and PBS (-) was added to each with a volume of 30%.
The suspension was diluted to a volume of 1 ml and then centrifuged (4 ° C., 400 rpm, 5 minutes).
After centrifugation, the fat was removed from the system except the supernatant. Next, 25 ml of PBS (-) was added to the residue to suspend it, and this was further centrifuged [(4 ° C., 400 rpm, 5 minutes) × 3 times]. The residue obtained by this centrifugation is a hair follicle in the back skin of the rat.

【0042】(2)毛包上皮系細胞の採取 上記操作により得られた毛包に、0.25%トリプシン
含有PBS(−)を5ml添加して、細胞懸濁液を37℃
で5分間インキュベートした。インキュベート終了後、
5mlの等量の牛胎児血清(FBS)とHam's F12
培地を添加して、細胞懸濁液をセルストレーナー(100
μm Nalgene 社製)で濾過後、50ml遠沈管に入れて、
この細胞懸濁液に遠心処理を施した(4℃,1500rp
m ,5分間)。この系から上清を除去して、残渣として
所望する毛包上皮系細胞を得た。
(2) Collection of hair follicle epithelial cells To the hair follicle obtained by the above operation, 5 ml of PBS (-) containing 0.25% trypsin was added, and the cell suspension was heated at 37 ° C.
For 5 minutes. After the incubation,
5 ml equal volumes of fetal bovine serum (FBS) and Ham's F12
Add medium and add cell suspension to cell strainer (100
μm Nalgene), and put into a 50 ml centrifuge tube.
This cell suspension was centrifuged (4 ° C., 1500 rp).
m, 5 minutes). The supernatant was removed from this system to obtain the desired hair follicle epithelial cells as a residue.

【0043】この毛包上皮系細胞に細胞凍結液(セルバ
ンカー:ダイヤトロン製)を添加し、1.5×107 ce
ll/ml の濃度に調整して、各凍結チューブに1.5×1
7cellずつ入れ、これを凍結保存した。なお、これら
の細胞数は、血球算定板で算出した。
A cell frozen solution (Cell Banker: manufactured by Diatron) was added to the hair follicle epithelial cells, and 1.5 × 10 7 ce
Adjust to a concentration of ll / ml and add 1.5x1 to each cryotube.
Put one by 0 7 cell, was frozen save it. In addition, these cell numbers were calculated with a blood cell counting plate.

【0044】2.毛包上皮系細胞の前培養:系に混入し
ている線維芽細胞を可能な限り系から除去するために、
上記工程により得られた毛包上皮系細胞の前培養を行っ
た。以下、その手順について説明する。37℃の恒温槽
で、上記工程により得た凍結細胞を融解した。次いでF
AD培地〔Ham's F12培地(後述)とMEN培地
を容量比で3対1で混合したものに、インシュリン(5.0
μg/ml),ハイドロコルチゾン(0.45μg/ml),エピダ
ーマルグロウスファクター(EGF)(10.0ng/ml),コレラト
キシン(10-9M)及びウシ胎児血清(10 %) を含有させ
た培地、以下同様である〕を10ml添加し、細胞溶液を
希釈して系に遠心処理を施した(10℃以下,1500
rpm ,5分間)。遠心後、上清を除去し、系にFAD培
地を10ml添加して、細胞塊が認められなくなるまでピ
ペッティングを繰り返した。
2. Preculture of hair follicle epithelial cells: To remove fibroblasts from the system as much as possible,
Preculture of hair follicle epithelial cells obtained by the above steps was performed. Hereinafter, the procedure will be described. The frozen cells obtained in the above steps were thawed in a thermostat at 37 ° C. Then F
AD medium [A mixture of Ham's F12 medium (described below) and MEN medium at a volume ratio of 3 to 1;
μg / ml), a medium containing hydrocortisone (0.45 μg / ml), epidermal growth factor (EGF) (10.0 ng / ml), cholera toxin (10 −9 M) and fetal bovine serum (10%), The same applies to the following), the cell solution was diluted, and the system was centrifuged (10 ° C. or less, 1500
rpm, 5 minutes). After centrifugation, the supernatant was removed, 10 ml of FAD medium was added to the system, and pipetting was repeated until no cell mass was observed.

【0045】得られた細胞数を血球算定板で算出し、F
AD培地で2.5×105 cell/mlの濃度になるように
調整した。I型コラーゲンでコーティングした75cm3
のフラスコに細胞を播種して、これを37℃,5%CO
2 で一晩培養した。培養後、系をPBS(−)10mlで
2回洗浄し、0.25%トリプシン含有PBS(−)を
2ml添加して、これを37℃,5%CO2 で4分間イン
キュベートした。次に、系に牛胎児血清(FBS)を2
ml添加して、1回軽くゆすった後で上清を除去して、系
に混入している線維芽細胞を除去した。
The number of cells obtained was calculated using a hemocytometer, and
It was adjusted to a concentration of 2.5 × 10 5 cell / ml in AD medium. 75cm 3 coated with type I collagen
Cells were seeded in a flask of 37 ° C., 5% CO 2
2 overnight. After the culture, the system was washed twice with 10 ml of PBS (-), 2 ml of PBS (-) containing 0.25% trypsin was added, and the mixture was incubated at 37 ° C and 5% CO 2 for 4 minutes. Next, 2 fetal bovine serum (FBS) was added to the system.
After adding once and gently rocking, the supernatant was removed to remove fibroblasts contaminating the system.

【0046】さらに、系にKGM培地〔表皮角化細胞基
礎培地(Keratinocyto growth medium):Keratinocyto b
asal medium (KBM培地(改変MCDB153培地
(クローネティックス社製)))に,ウシ脳下垂体エキ
ス(BPE)(0.4vol%),インシュリン(0.5μm/ml),ハイドロ
コルチゾン(0.5μm/ml),h-EGF(0.1 ng/ml)を添加した培
地、以下同様である〕を15ml添加し、37℃,5%C
2 で3日間培養した。
Further, a KGM medium [Keratinocyto growth medium: Keratinocytob medium] was added to the system.
bovine pituitary extract (BPE) (0.4 vol%), insulin (0.5 μm / ml), hydrocortisone (0.5 μm / ml) in an asal medium (KBM medium (modified MCDB153 medium (Clonetics))) , h-EGF (0.1 ng / ml), the same applies to the following.
Cultured in O 2 for 3 days.

【0047】3.対象物質のアッセイ 上記工程により得た毛包上皮系細胞を播種した培養フラ
スコの線維芽細胞混入率(FB混入率)を測定(300
0倍,5視野)し、その結果FB混入率が3%以上のも
のは、アッセイの対象から除外した。系をPBS(−)
10mlで2回洗浄し、0.25%トリプシン含有PBS
(−)を2ml添加して、これを37℃で3分間インキュ
ベートした。次いで上皮系細胞と線維芽細胞とのトリプ
シンに対する反応性の違いを利用して,系から線維芽細
胞を除去するために、トリプシンを除去し、再び0.2
5%トリプシン含有PBS(−)を2ml添加して、37
℃,20rpm で5分間振盪した。
3. Assay of target substance Measure the fibroblast contamination rate (FB contamination rate) of the culture flask in which the hair follicle epithelial cells obtained by the above steps were seeded (300).
(0 times, 5 fields of view), and as a result, those having a FB contamination rate of 3% or more were excluded from the subject of the assay. The system is PBS (-)
After washing twice with 10 ml, PBS containing 0.25% trypsin
2 ml of (-) was added, and this was incubated at 37 ° C. for 3 minutes. Taking advantage of the difference in reactivity between epithelial cells and fibroblasts with trypsin, trypsin was removed in order to remove fibroblasts from the system, and 0.2 times again.
2 ml of PBS (-) containing 5% trypsin was added, and 37
The mixture was shaken at 20 rpm for 5 minutes.

【0048】次いで、細胞のはがれを顕微鏡下で確認し
た後、10%FBS含有DMEM培地を10ml添加し
て、50ml遠心チューブ中でピペッティングを行い、系
を1500rpm で5分間遠心処理を施した。上清を除去
し、KGM培地20mlを添加して、細胞塊がなくなるま
でピペッティングを行った。懸濁液をセルストレーナー
(100 μm Nalgene 社製)で濾過後、50ml遠沈管に入
れて、懸濁液中の生細胞数を血球算定板で算出し、系に
KGM培地を添加して、系の中の細胞濃度が5.0×1
4cell/mlになるように調整した。
Then, after confirming the detachment of the cells under a microscope, 10 ml of 10% FBS-containing DMEM medium was added, pipetting was performed in a 50 ml centrifuge tube, and the system was centrifuged at 1500 rpm for 5 minutes. The supernatant was removed, 20 ml of KGM medium was added, and pipetting was performed until there was no cell mass. The suspension was filtered through a cell strainer (100 μm, manufactured by Nalgene), put into a 50 ml centrifuge tube, the number of viable cells in the suspension was calculated using a hemocytometer, and KGM medium was added to the system. Cell concentration in 5.0 × 1
0 4 was adjusted to cell / ml.

【0049】次いで、0.2ml/well の割合で、96we
ll-plate(I型コラーゲンコーティングプレート:ファ
ルコン社製)に播種し(1.0×104cell/well)、細
胞がウエルの底に沈むまで約20分間室温下で放置し
た。その後、37℃,5%CO2 で1日間培養を行い、
所望するヒト毛包上皮系培養細胞を得た。
Then, at a rate of 0.2 ml / well, 96we
The cells were seeded on an ll-plate (type I collagen coated plate: manufactured by Falcon) (1.0 × 10 4 cells / well), and left at room temperature for about 20 minutes until the cells sank to the bottom of the well. Thereafter, the cells were cultured at 37 ° C. and 5% CO 2 for 1 day,
The desired cultured human hair follicle epithelial cells were obtained.

【0050】C.試験培地の調製: (1)抽出物の調製 市販のコンフリー(乾燥物)500g を、7.5l の3
0%エタノールに室温(23℃)で5日間浸漬した。抽
出液から溶媒を留去し、コンフリーの30%エタノール
抽出乾燥物50g を得た。また、市販のカモミラ(乾燥
物)500g を、7.5l の水に室温(23℃)で5日
間浸漬した。抽出液から溶媒を留去し、次いで乾燥して
カモミラの水抽出乾燥物100g を得た。
C. Preparation of test medium: (1) Preparation of extract 500 g of commercially available comfrey (dry matter) was added to 7.5 l of 3
It was immersed in 0% ethanol at room temperature (23 ° C.) for 5 days. The solvent was distilled off from the extract to obtain 50 g of a comfree 30% ethanol extract dry product. Further, 500 g of commercially available chamomile (dried product) was immersed in 7.5 l of water at room temperature (23 ° C.) for 5 days. The solvent was distilled off from the extract and then dried to obtain 100 g of an aqueous extract of chamomile.

【0051】その他の植物抽出物についても、市販の該
当する植物(原則として乾燥物)を入手して、下記第1
表に示す抽出方法で抽出して、それぞれの乾燥抽出物を
調製した。なお、ローヤルゼリーは市販のローヤルゼリ
ー粉末を用いた。
Regarding other plant extracts, commercially available corresponding plants (in principle, dried products) were obtained and
Each dried extract was prepared by extraction according to the extraction method shown in the table. The royal jelly used was a commercially available royal jelly powder.

【0052】(2)対象物質添加培地の調製 対象物質を約1.5mgスクリュー管に秤量し、有機溶剤
(DMSO)で0.2%溶液になるように調製した。次
いで、上記の生薬抽出物のDMSO溶液を1000倍量
の前記KBM培地に添加した〔抽出物濃度:2.0×1
-4%(DMSO 0.1%)〕。
(2) Preparation of Target Substance-Added Medium About 1.5 mg of the target substance was weighed into a screw tube, and prepared with an organic solvent (DMSO) to a 0.2% solution. Next, a DMSO solution of the crude drug extract was added to the KBM medium in a 1000-fold amount [extract concentration: 2.0 × 1
0 -4 % (DMSO 0.1%)].

【0053】なお、対象物質として用いた生薬抽出物等
は、コンフリー抽出物,アルニカ抽出物,ハッカ末,ダ
イズ抽出物,キナ抽出物,スギナ抽出物,チョウジ抽出
物,ホップ抽出物,シソ抽出物,アセンヤク抽出物,ア
ズキ末,サイシン抽出物,チンピ抽出物,ケイヒ抽出
物,ブクリョウ抽出物,アロエ抽出物,レイシ抽出物,
ゲンチアナ抽出物,カンゾウ抽出物(カンゾウフラボノ
イドを含む),ショウブ根.ウコン抽出物,トウヒ抽出
物,ステビア抽出物,サンザシ抽出物,センキュウ抽出
物,タイソウ抽出物,サフラン抽出物,ヒキオコシ抽出
物,ヨクイニン抽出物,アンズ核粒抽出物,コリアンダ
ー抽出物,チョウセンアサガオ抽出物及びローヤルゼリ
ーであった。
The crude drug extract used as the target substance includes comfrey extract, arnica extract, peppermint powder, soybean extract, kina extract, horsetail extract, clove extract, hop extract, perilla extract. Products, Acacia extract, Azuki powder, Saishin extract, Chimney extract, Cauliflower extract, Bucurio extract, Aloe extract, Reishi extract,
Gentian extract, licorice extract (including licorice flavonoids), shobu root. Turmeric extract, Spruce extract, Stevia extract, Hawthorn extract, Senkyu extract, Tiso extract, Saffron extract, Hioki sorghum extract, Yokunin extract, Apricot kernel particle extract, Coriander extract, Datura extract And royal jelly.

【0054】また同様に対照として、チャ抽出物(抽出
法:水抽出),バクモンドウ抽出物(抽出法:10%エ
タノール抽出)の0.2%DMSO溶液を調製した。こ
れらの対象物質添加培地0.2mlを、0.1%DMSO
含有KBM培地1.8mlに添加し、対象物質の濃度を
2.0×10-5%になるように調製した(10倍希
釈)。
Similarly, as a control, a 0.2% DMSO solution of a tea extract (extraction method: water extraction) and a Bacmondou extract (extraction method: 10% ethanol extraction) were prepared. 0.2 ml of these target substance-supplemented media was added to 0.1% DMSO
It was added to 1.8 ml of the KBM medium containing the mixture, and the concentration of the target substance was adjusted to 2.0 × 10 −5 % (10-fold dilution).

【0055】(2)コントロール培地の調製 ・ネガティブコントロール:KBM培地2mlに、DMS
Oを 2μl 添加して調製した(DMSO 0.1
%)。 ・ポジティブコントロール:ネガティブコントロール培
地に、インシュリン(5mg/ml)を2μl ,ハイドロコー
チゾン(0.5mg/ml)を2μl 添加して調製した。
(2) Preparation of control medium Negative control: DMS was added to 2 ml of KBM medium.
O (2 μl) was added (DMSO 0.1
%). Positive control: A negative control medium was prepared by adding 2 μl of insulin (5 mg / ml) and 2 μl of hydrocortisone (0.5 mg / ml).

【0056】D.対象物質培地交換:上記A,Bにおい
てヒト毛包上皮系培養細胞及びラット毛包上皮系培養細
胞を調製した96well-plate中のKGM培地を、対象物
質添加培地及びコントロール培地(200μl/well)と
交換して、交換後37℃,5%CO2 で2日間培養し
た。
D. Object substance culture medium exchange: The KGM medium in the 96-well-plate prepared with human hair follicle epithelial cell culture cells and rat hair follicle epithelial cell culture cells in A and B above was replaced with a target substance-added medium and a control medium (200 μl / well). After the exchange, the cells were cultured at 37 ° C. and 5% CO 2 for 2 days.

【0057】なお、この培地の交換はウエル内のKGM
培地を,底面に付着している細胞を傷つけないように留
意しつつアスピレーターで抜いて、その後速やかに対象
物質添加培地等をウエルの両端から添加することにより
行った。
The exchange of the medium was performed using KGM in the well.
The medium was removed with an aspirator, taking care not to damage the cells adhering to the bottom, and then the medium containing the target substance was immediately added from both ends of the well.

【0058】E.細胞増殖の測定:アラマーブルー(ala
mar blue:アラマーバイオサイエンス社製) を培地量
(容量)に対して、1/10量を添加して、37℃(5
%CO2 )で6時間インキュベートした。インキュベー
ト後、系の595nm及び570nmでの吸光度をマイクロ
プレートリーダー(Micro plate reader:Bio RAD社製)
を用いて測定し、下記計算式に従って,細胞増殖度を算
出した。
E. Cell proliferation measurement: alamar blue (ala
mar blue (manufactured by Alamar Biosciences, Inc.) was added at 1/10 the volume (volume) of the medium, and the mixture was added at 37 ° C (5
% CO 2 ) for 6 hours. After the incubation, the absorbance of the system at 595 nm and 570 nm was measured using a microplate reader (Micro RAD).
The cell proliferation was calculated according to the following formula.

【0059】[0059]

【数1】 (Equation 1)

【0060】また、ここで算出した細胞増殖度を基にし
て、細胞増殖促進指標を下記式に従って算出した。
The cell growth promotion index was calculated according to the following equation based on the cell growth degree calculated here.

【数2】 (Equation 2)

【0061】F.結果:測定した上記各対象物質におけ
る、上記細胞増殖度を下記第1表に示す。
F. Results: Table 1 below shows the cell proliferation degree of each of the measured target substances.

【表1】 [Table 1]

【0062】この結果より、上記成分に毛包上皮系培養
細胞の増殖活性が確かに認められた。すなわち、上記成
分には毛髪上皮系細胞の分裂増殖活性の維持による、毛
髪における成長期の維持,延長作用が認められることが
明らかになった。
From these results, it was confirmed that the above-mentioned components showed the growth activity of hair follicle epithelial cultured cells. In other words, it was revealed that the above-mentioned components have the effect of maintaining and prolonging the anagen phase in hair by maintaining the mitotic proliferation activity of hair epithelial cells.

【0063】〔試験例2〕 テストステロン−5α−レ
ダクターゼ阻害活性の測定:対象物質の5α−レダクタ
ーゼの阻害作用を、テストステロンから,いわゆる作用
型アンドロゲンと称される5α−ジヒドロテストステロ
ンへの変換に関与する,テストステロン−5α−レダク
ターゼに対する阻害活性をin vitroで評価することで特
定する試験について説明する。
Test Example 2 Measurement of testosterone-5α-reductase inhibitory activity: The inhibitory effect of the target substance on 5α-reductase is involved in the conversion of testosterone to 5α-dihydrotestosterone, which is a so-called active androgen. A test to be specified by evaluating the inhibitory activity on testosterone-5α-reductase in vitro will be described.

【0064】テストステロン−5α−レダクターゼ阻害
活性に関する対象物質の効果は、高安らの方法〔S.Taka
yasu, K. Adachi, J. Clin. Endrocrinol. Metab.,34,1
098-1101(1972)〕に従って行うことができる。すなわ
ち、人毛根を用い、テストステロンが5α−ジヒドロテ
ストステロン(5α−DHTともいう)に還元される量
を測定し、各対象物質(乾燥物)の0.1%,70%エ
タノール溶液について、テストステロン−5α−レダク
ターゼ阻害活性を測定し、以下の式に従って阻害率を求
めることによって特定することができる。
The effect of the target substance on testosterone-5α-reductase inhibitory activity was determined by the method of Takayasu et al. [S.
yasu, K. Adachi, J. Clin. Endrocrinol. Metab., 34, 1
098-1101 (1972)]. That is, the amount of testosterone reduced to 5α-dihydrotestosterone (also referred to as 5α-DHT) was measured using human hair roots, and 0.1% and 70% ethanol solutions of each target substance (dry matter) were tested. It can be specified by measuring the 5α-reductase inhibitory activity and determining the inhibition rate according to the following formula.

【0065】[0065]

【数3】 (Equation 3)

【0066】対象物質は、ジャンカン,ウォロ,レグ
ロ,ダウン・トラワズ,コリアンダー,シャクヤク,ヨ
クイニン,ボケ,ヒワの各々の抽出物を用いた。なお、
各抽出物は前述の抽出方法によりそれぞれ抽出した。例
えば、シャクヤクの抽出物は、市販のシャクヤク(乾燥
物)500g を、7.5l の水で5日間浸漬し、この抽
出液から水を留去し、次いで乾燥させてシャクヤクの水
抽出乾燥物100g を得た。また、対照としてサイコの
抽出物を用いた。この結果を、第2表に示す。
As the target substances, extracts of Jankan, Woro, Legro, Down troars, Coriander, Peony, Yokuinin, Bokeh and Hikawa were used. In addition,
Each extract was extracted by the aforementioned extraction method. For example, as an extract of a peony, 500 g of a commercially available peony (dried product) is immersed in 7.5 l of water for 5 days, water is distilled off from the extract, and then dried to obtain 100 g of a dried aqueous extract of a peony. I got In addition, a psycho extract was used as a control. The results are shown in Table 2.

【0067】[0067]

【表2】 [Table 2]

【0068】この結果により、ジャンカン,ウォロ,レ
グロ,ダウン・トラワズ,コリアンダー,シャクヤク,
ヨクイニン,ボケ及びヒワの各抽出物には、明らかに5
α−レダクターゼ阻害作用が認められた。
According to this result, Jankan, Woro, Legro, Down Trawas, Coriander, Peony,
The extract of yokuinin, bokeh and mulberry clearly has 5
An α-reductase inhibitory action was observed.

【0069】以下、本発明育毛剤の処方を実施例として
示し、さらにこれらの育毛効果の検討を行った。 〔比較例〕 比較例としての液状育毛剤の調製 上述したコンフリーの30%エタノール乾燥物0.1%
を、70%エタノール90%、オレイン酸ナトリウム
0.1%、ドデシルベンゼンスルホン酸0.49%、硬
化ヒマシ油エチレンオキシド(40モル)付加物0.5
%及びイオン交換水(残余)と混合攪拌して溶解させ
た。さらにイオン交換水(10%)を添加混合して、液
状の養毛剤を得た(比較例2)。
Hereinafter, the formulations of the hair restorer of the present invention are shown as examples, and their hair restorer effects were further examined. [Comparative Example] Preparation of Liquid Hair Restorative as Comparative Example 0.1% of 30% ethanol dried product of Comfrey described above
Are prepared by adding 70% ethanol 90%, sodium oleate 0.1%, dodecylbenzenesulfonic acid 0.49%, hydrogenated castor oil ethylene oxide (40 mol) adduct 0.5
% And ion-exchanged water (residual) and dissolved by stirring. Further, ion-exchanged water (10%) was added and mixed to obtain a liquid hair restorer ( Comparative Example 2 ).

【0070】この液状の養毛剤の処方において、上述し
たバクモンドウの10%エタノール抽出物の乾燥物0.
1%を、上記のコンフリーの30%エタノール乾燥物
0.1%に代えて調製した液状の剤を対照として調製し
た(比較例1)。また、上述したシャクヤクの水抽出乾
燥物0.1%を70%エタノール90%、オレイン酸ナ
トリウム0.1%、ドデシルベンゼンスルホン酸0.4
9%、硬化ヒマシ油エチレンオキシド(40モル)付加
物0.5%及びイオン交換水(残余)と混合攪拌して溶
解させた。さらにイオン交換水(10%)を添加混合し
て、液状の養毛料を得た(比較例3)。
In the formulation of this liquid hair restorer, the dried product of the above-mentioned 10% ethanol extract of Bacmondou was prepared.
A liquid agent prepared by replacing 1% with 0.1% of the above comfrey 30% ethanol dried product was prepared as a control ( Comparative Example 1 ). Also, 0.1% of the above-mentioned dried water-dried peony is 70% ethanol 90%, sodium oleate 0.1%, dodecylbenzenesulfonic acid 0.4%.
9%, 0.5% of hydrogenated castor oil ethylene oxide (40 mol) adduct and ion-exchanged water (residual) were mixed and dissolved by stirring. Further, ion-exchanged water (10%) was added and mixed to obtain a liquid hair restorative ( Comparative Example 3 ).

【0071】〔実施例1〕 液状育毛剤の調製 上述したコンフリーの30%エタノール乾燥物0.05
%と、シャクヤクの水抽出乾燥物0.05%を、70%
エタノール90%、オレイン酸ナトリウム0.1%、ド
デシルベンゼンスルホン酸0.49%、硬化ヒマシ油エ
チレンオキシド(40モル)付加物0.5%及びイオン
交換水(残余)と混合攪拌して溶解させて、さらにイオ
ン交換水(10%)を添加混合して、液状育毛剤を得
た。
Example 1 Preparation of Liquid Hair Restoration Agent The above comfrey 30% ethanol dried product 0.05
% And dried peony with water extract 0.05%, 70%
Mix with 90% ethanol, 0.1% sodium oleate, 0.49% dodecylbenzenesulfonic acid, 0.5% hydrogenated castor oil ethylene oxide (40 mol) adduct and 0.5% ion-exchanged water (residual) to dissolve. Further, ion-exchanged water (10%) was added and mixed to obtain a liquid hair restorer.

【0072】〔試験例3〕 本発明育毛剤の育毛作用の
検討 本発明育毛剤の脱毛防止、発毛効果等の育毛作用を調べ
るために、以下の方法でヒトに対してトリコグラム試験
及び実使用テストを実施した。被験試料及び対照試料
は、実施例1の本発明育毛剤、比較例1〜3の剤及び7
0%エタノールである。
Test Example 3 Examination of the Hair Restoring Effect of the Hair Restoration Agent of the Present Invention In order to examine the hair restoring effect such as the hair loss preventing effect and the hair growth effect of the hair restoring agent of the present invention, a tricogram test was carried out on humans by the following method and the test was carried out. A usage test was conducted. The test sample and the control sample were the hair growth agent of the present invention of Example 1, the agents of Comparative Examples 1 to 3, and 7
0% ethanol.

【0073】試験方法 上記試料の使用前と使用後の抜去毛髪の毛根を顕微鏡下
で観察し、毛根の形態から,成長の止まった毛の毛根で
ある「休止期毛根」数を計数し、その割合の増減によっ
てこれらの試料の育毛作用を比較した。すなわち、被験
試料及び対照試料をそれぞれ男性被験者10名の頭皮に
1日2回、1回2mlずつ6カ月間連続して塗布し、塗布
直前および6カ月間塗布終了直後に被験者1名につき1
00本ずつ毛髪を抜去し、それぞれの毛根を顕微鏡下で
観察した。また、上記試料の育毛効果が有効か無効かに
関する実使用テストを行った。
Test Method The roots of the extracted hair before and after use of the above sample were observed under a microscope, and the number of “resting roots”, which are the roots of the growth-stopped hairs, were counted from the morphology of the roots. The hair growth effects of these samples were compared by increasing or decreasing the ratio. That is, each of the test sample and the control sample was applied to the scalp of 10 male subjects twice a day, 2 ml at a time, continuously for 6 months.
The hair was removed by 00 hairs, and each hair root was observed under a microscope. In addition, an actual use test was performed on whether the hair growth effect of the sample was effective or ineffective.

【0074】これらの試験の結果を、下記第3表に示
す。
The results of these tests are shown in Table 3 below.

【表3】 [Table 3]

【0075】この第3表の結果から、比較例1はもとよ
り、成長期延長成分であるコンフリー抽出物又は5α−
レダクターゼ阻害成分であるシャクヤクの抽出物のいず
れかを配合した比較例2及び3よりも、この2種類の抽
出物を総量で同量配合した実施例1の育毛効果が相乗的
に優れていることが判明した。このことより、作用機序
の異なる2種類の育毛成分を組み合わせて用いることに
より、相乗的に育毛効果が向上した本発明育毛剤が提供
される。
From the results shown in Table 3, not only Comparative Example 1 but also Comfrey extract or 5α-
Compared with Comparative Examples 2 and 3 in which one of the extracts of the peony which is a reductase inhibitory component was used, the hair growth effect of Example 1 in which the two types of extracts were combined in the same amount in total was synergistically superior. There was found. From this, the hair restorer of the present invention, which has a synergistically improved hair restorer effect by using two types of hair restorer components having different action mechanisms in combination, is provided.

【0076】以下、上記の剤型以外の本発明育毛剤を実
施例として例示する。 〔実施例2〕 乳液型育毛剤の調製 (配合成分) 配合量(重量%) (A相) コンフリー抽出乾燥物 0.5 シャクヤク抽出乾燥物 0.5 ポリオキシエチレン(60モル)付加硬化ヒマシ油 2.0 グリセリン 10.0 ジプロピレングリコール 10.0 1,3−ブチレングリコール 5.0 ポリエチレングリコール1500 5.0 (B相) セチルイソオクタネート 10.0 スクワラン 5.0 ワセリン 2.0 プロピルパラペン 2.0 (C相) カルボキシビニルポリマー1%水溶液 30.0 ヘキサメタリン酸ソーダ 0.03 イオン交換水 8.35 (D相) イオン交換水 4.5 (E相) カセイカリ 0.12 イオン交換水 5.0
Hereinafter, hair growth agents of the present invention other than the above-mentioned dosage forms will be exemplified as examples. [Example 2] Preparation of emulsion type hair restorer (Blending components) Blending amount (% by weight) (Phase A) Comfrey extract dried product 0.5 Peony extract dried product 0.5 Polyoxyethylene (60 mol) addition-cured castor Oil 2.0 Glycerin 10.0 Dipropylene glycol 10.0 1,3-butylene glycol 5.0 Polyethylene glycol 1500 5.0 (Phase B) Cetyl isooctanoate 10.0 Squalane 5.0 Vaseline 2.0 Propyl parapen 2.0 (C phase) Carboxyvinyl polymer 1% aqueous solution 30.0 Sodium hexametaphosphate 0.03 Ion exchange water 8.35 (D phase) Ion exchange water 4.5 (E phase) Kaseikari 0.12 Ion exchange water 5 .0

【0077】<製造法>A相、B相をそれぞれ60℃で
加熱溶解し、混合してホモミキサー処理しゲルを調製
し、これにD相を徐々に添加しホモミキサーで分散し
た。次にこれに溶解したC相を加え、最後に溶解したE
相を添加しホモミキサーで乳化して、O/W乳液型の育
毛料を得た。
<Production Method> Phases A and B were each heated and dissolved at 60 ° C., mixed and treated with a homomixer to prepare a gel, and phase D was gradually added thereto and dispersed with a homomixer. Next, dissolved C phase was added thereto, and finally dissolved E
The phase was added and emulsified with a homomixer to obtain an O / W emulsion type hair restorer.

【0078】〔実施例3〕 クリーム状育毛剤の調製 上述のコンフリーの30%エタノール乾燥物0.5%
と、シャクヤクの水抽出乾燥物0.5%を用いて、以下
のようにクリーム状の実施例7を調製した。 (配合成分) 配合量(重量%) (A相) 流動パラフィン 5.0 セトステアリルアルコール 5.5 グリセリルモノステアレート 3.0 EO(20モル)−2−オクチルドデシルエーテル 8.0 プロピルパラベン 0.3 香料 0.1 (B相) コンフリー抽出乾燥物 0.5 シャクヤク抽出乾燥物 0.5 グリセリン 8.0 ジプロピレングリコール 20.0 ポリエチレングリコール4000 5.0 ドデシル硫酸ナトリウム 0.1 ヘキサメタリン酸ソーダ 0.005 イオン交換水 43.995
[Example 3] Preparation of creamy hair restorer 0.5% of the above comfrey 30% ethanol dried product
And 0.5% of a dried water-extracted product of a peony was used to prepare a creamy Example 7 as follows. (Blending components) Blending amount (% by weight) (A phase) Liquid paraffin 5.0 cetostearyl alcohol 5.5 glyceryl monostearate 3.0 EO (20 mol) 2-octyldodecyl ether 8.0 propylparaben 3 Fragrance 0.1 (Phase B) Comfrey extract dried product 0.5 Peony extract dried product 0.5 Glycerin 8.0 Dipropylene glycol 20.0 Polyethylene glycol 4000 5.0 Sodium dodecyl sulfate 0.1 Sodium hexametaphosphate 0 0.005 ion-exchanged water 43.995

【0079】<製造法>A相、B相をそれぞれ加熱溶解
して混合し、ホモミキサーで乳化して、クリーム状養毛
料を調製した。
<Production Method> The phases A and B were each dissolved by heating, mixed and emulsified by a homomixer to prepare a creamy hair restorer.

【0080】[0080]

【発明の効果】本発明により、異なる作用機序の養毛成
分を配合することによる相乗的な育毛作用を示す育毛剤
が提供される。
Industrial Applicability According to the present invention, there is provided a hair restorer exhibiting a synergistic hair restorer action by combining hair nourishing components having different action mechanisms.

─────────────────────────────────────────────────────
────────────────────────────────────────────────── ───

【手続補正書】[Procedure amendment]

【提出日】平成10年1月30日[Submission date] January 30, 1998

【手続補正1】[Procedure amendment 1]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0039[Correction target item name] 0039

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0039】B.ラット毛包上皮系細胞 1.ラット毛包上皮系細胞の採取: (1)毛包の採取 新生児(3〜4日令)のラットの背部皮膚を採取し、こ
の採取した背部皮膚を1%PSF含有PBS(−)に2
枚ずつ浸した。その後、皮膚脂肪層から下の皮下脂肪や
皮膜等を解剖用ハサミで除去した。次いで、再びこの背
部皮膚を1%PSF含有PBS(−)に浸し、さらにこ
れを0.25%トリプシン含有PBS(−)(0.02
%EDTA含む。以下、同様である。)中に4℃で一晩
浸した。
B. Rat hair follicle epithelial cells 1. Collection of rat hair follicle epithelial cells: (1) Collection of hair follicle The back skin of a newborn (3 to 4 day old) rat was collected, and the collected back skin was added to PBS (-) containing 1% PSF for 2 hours.
Soaked one by one. Thereafter, the subcutaneous fat, skin, and the like below the skin fat layer were removed with scissors for dissection. Next, the back skin was immersed again in PBS (-) containing 1% PSF, and further immersed in PBS (-) containing 0.25% trypsin (0.02).
% EDTA included. Hereinafter, the same applies. ) At 4 ° C. overnight.

フロントページの続き (51)Int.Cl.6 識別記号 FI A61K 35/78 A61K 35/78 J Q H N K ADA ADAR 35/84 35/84 A (72)発明者 中沢 陽介 神奈川県横浜市港北区新羽町1050番地 株 式会社資生堂第1リサーチセンター内 (72)発明者 田島 正裕 神奈川県横浜市港北区新羽町1050番地 株 式会社資生堂第1リサーチセンター内Continuation of the front page (51) Int.Cl. 6 Identification code FI A61K 35/78 A61K 35/78 JQHNKADA ADAR 35/84 35/84 A (72) Inventor Yosuke Nakazawa Kohoku-ku, Yokohama-shi, Kanagawa 1050 Nippacho, Shiseido First Research Center Co., Ltd. (72) Inventor Masahiro Tajima 1050 Nippacho, Kohoku-ku, Yokohama, Kanagawa Prefecture, Shiseido No.1 Research Center

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】テストステロン−5α−レダクターゼを阻
害する作用を有する成分及び毛周期における成長期を維
持若しくは延長する作用を有する成分を有効成分とする
育毛剤。
1. A hair restorer comprising as an active ingredient a component having an action of inhibiting testosterone-5α-reductase and a component having an action of maintaining or prolonging the anagen phase in the hair cycle.
【請求項2】毛周期における成長期を維持若しくは延長
する作用を有する成分が、毛包上皮系細胞を増殖させる
活性を有する成分である、請求項1記載の育毛剤。
2. The hair restorer according to claim 1, wherein the component having an action of maintaining or prolonging the anagen phase in the hair cycle is a component having an activity of expanding hair follicle epithelial cells.
【請求項3】毛包上皮系細胞を増殖させる活性を有する
成分が、コンフリー抽出物,ウコン抽出物,タイソウ抽
出物,コリアンダー抽出物,チョウセンアサガオ抽出
物,サイシン抽出物,ヨクイニン抽出物,ステビア抽出
物,アセンヤク抽出物,ゲンチアナ抽出物,ホップ抽出
物,ヒキオコシ抽出物,アズキ抽出物,アルニカ抽出
物,ハッカ抽出物,カンゾウ抽出物,ブクリョウ抽出
物,ダイズ抽出物,シソ抽出物,キナ抽出物,スギナ抽
出物,アンズ核粒抽出物,サンザシ抽出物,センキュウ
抽出物,ケイヒ抽出物,レイシ抽出物,チョウジ抽出
物,トウヒ抽出物及びローヤルゼリーからなる群の成分
から選ばれる1種又は2種以上の成分である、請求項2
記載の育毛剤。
3. A component having an activity of proliferating hair follicle epithelial cells is a comfrey extract, a turmeric extract, a scallop extract, a coriander extract, a ginseng extract, a cycin extract, a yoquinin extract, or stevia. Extracts, Acacia catechu extract, Gentian extract, Hop extract, Hioki sorghum extract, Adzuki bean extract, Arnica extract, Mentha extract, Licorice extract, Bucurio extract, Soybean extract, Perilla extract, Kina extract One or two or more selected from the group consisting of radish extract, horse chestnut extract, apricot kernel extract, hawthorn extract, rose extract, cinnamon extract, litchi extract, clove extract, spruce extract and royal jelly 3. The component of claim 2,
The hair restorer according to the above.
JP9091537A 1997-03-26 1997-03-26 Hair tonic Pending JPH10265350A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9091537A JPH10265350A (en) 1997-03-26 1997-03-26 Hair tonic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9091537A JPH10265350A (en) 1997-03-26 1997-03-26 Hair tonic

Publications (1)

Publication Number Publication Date
JPH10265350A true JPH10265350A (en) 1998-10-06

Family

ID=14029225

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9091537A Pending JPH10265350A (en) 1997-03-26 1997-03-26 Hair tonic

Country Status (1)

Country Link
JP (1) JPH10265350A (en)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10265349A (en) * 1997-03-26 1998-10-06 Shiseido Co Ltd Hair tonic
JP2000256175A (en) * 1999-03-15 2000-09-19 Rasheru Seiyaku Kk Cosmetic composition
JP2000302667A (en) * 1999-04-23 2000-10-31 Kobe Tennenbutsu Kagaku Kk Accelerator for ample breasts
JP2002173416A (en) * 2000-12-06 2002-06-21 Kao Corp Hair cosmetic
JP2002322050A (en) * 2001-04-25 2002-11-08 Kenji Uehara Hair growth agent
JP2003192541A (en) * 2001-12-26 2003-07-09 Pola Chem Ind Inc Hair growth-promoting agent and skin care preparation for hair growth
JP2005035903A (en) * 2003-07-16 2005-02-10 Lion Corp Hair-restoring and growing agent composition
WO2005034894A1 (en) * 2003-10-09 2005-04-21 Advangen, Inc. Hair growth stimulant composition
JP2007051075A (en) * 2005-08-16 2007-03-01 Keio Gijuku Method for preparing plant extract, plant extract and its application
WO2009123211A1 (en) 2008-03-31 2009-10-08 株式会社資生堂 Agents for maturing, normalizing or stabilizing blood vessels and wrinkle-preventing and improving agents
WO2009154237A1 (en) 2008-06-18 2009-12-23 株式会社資生堂 Stabilizer for lymph vessel
EP1727511A4 (en) * 2004-03-16 2010-04-28 Lg Household & Health Care Ltd Hair growth agent composition
KR101040011B1 (en) * 2009-01-30 2011-06-08 유형준 Demodex folliculorum germicide
JP2013245172A (en) * 2012-05-24 2013-12-09 Nippon Menaade Keshohin Kk Trichogenous agent
JP2014172896A (en) * 2013-03-12 2014-09-22 Kyoei Kagaku Kogyo Kk Hair composition
JP2016527258A (en) * 2013-07-29 2016-09-08 エボニック デグサ ゲーエムベーハーEvonik Degussa GmbH Formulation containing sphinganine
JP2017137314A (en) * 2016-02-03 2017-08-10 イチバンライフ株式会社 Composition for head
CN115466713A (en) * 2022-09-30 2022-12-13 北京熙朵医疗美容门诊部有限公司 Hair follicle activating solution for CHT living cell hair transplantation technology and preparation method thereof

Citations (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60146829A (en) * 1984-01-05 1985-08-02 Rooto Seiyaku Kk Testosterone 5alpha-reductase inhibitor
JPS60174706A (en) * 1984-02-21 1985-09-09 Kao Corp Hair tonic
JPS63211214A (en) * 1987-02-26 1988-09-02 Sunstar Inc Hair tonic
JPS63284125A (en) * 1987-05-15 1988-11-21 Ichimaru Pharcos Co Ltd Testosterone 5alpha-reductase inhibitor
JPH01233207A (en) * 1988-03-15 1989-09-19 Chiyuuwa Internatl:Kk Hair tonic
JPH01246211A (en) * 1987-12-10 1989-10-02 Pola Chem Ind Inc Hair-restoring or growing accelerator
JPH0217117A (en) * 1988-07-06 1990-01-22 Shin Nippon Koeki Kk Hair tonic
JPH0217118A (en) * 1988-07-05 1990-01-22 Zenichi Ogita Japanese and chinese drug for hair growth
JPH0248514A (en) * 1988-08-11 1990-02-19 Shiseido Co Ltd Hair tonic
JPH0248515A (en) * 1988-08-11 1990-02-19 Shiseido Co Ltd Hair tonic
JPH02111710A (en) * 1988-10-20 1990-04-24 Akio Fujikawa Cosmetic composition
JPH02275815A (en) * 1989-04-17 1990-11-09 Kanebo Ltd Hair-tonic cosmetic
JPH0344312A (en) * 1989-07-04 1991-02-26 Tokugen Shu Production of hair tonic
JPH0366606A (en) * 1989-08-03 1991-03-22 Shimizu Takao Hair tonic of compound crude drug
JPH03188014A (en) * 1989-12-15 1991-08-16 Shiseido Co Ltd Cosmetic
JPH03188013A (en) * 1989-12-15 1991-08-16 Shiseido Co Ltd Testosterone-5alpha-reductase inhibitor
JPH05255102A (en) * 1992-03-13 1993-10-05 Shiseido Co Ltd Testosterone-5-alpha-reductase inhibitor
JPH06172132A (en) * 1992-12-11 1994-06-21 Lion Corp Hair growing agent composition
JPH06227949A (en) * 1993-02-05 1994-08-16 Tomomi Kai Hair growth agent
JPH07206647A (en) * 1994-01-26 1995-08-08 Shiseido Co Ltd Hair tonic
JPH07278003A (en) * 1994-04-11 1995-10-24 Narisu Keshohin:Kk Testosterone-5alpha-reductase inhibitor
JPH0826937A (en) * 1994-07-12 1996-01-30 Daimu Internatl Kk Hair-raising agent
JPH0873324A (en) * 1994-09-06 1996-03-19 Kao Corp Hair-tonic and hair-growing agent
JPH08127518A (en) * 1994-09-07 1996-05-21 Dai Ichi Seiyaku Co Ltd Composition for hair
JPH09176031A (en) * 1995-12-28 1997-07-08 Shiseido Co Ltd Use of coriandrum plant extract
JPH09221413A (en) * 1996-02-14 1997-08-26 Noevir Co Ltd Hair tonic
JPH1036229A (en) * 1996-07-18 1998-02-10 Mandamu:Kk Stevia extract and hair growth composition
JPH10265347A (en) * 1997-03-26 1998-10-06 Shiseido Co Ltd Agent for extending hair growth period
JPH10265349A (en) * 1997-03-26 1998-10-06 Shiseido Co Ltd Hair tonic
JP3472072B2 (en) * 1997-03-26 2003-12-02 株式会社資生堂 Hair growth extender

Patent Citations (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60146829A (en) * 1984-01-05 1985-08-02 Rooto Seiyaku Kk Testosterone 5alpha-reductase inhibitor
JPS60174706A (en) * 1984-02-21 1985-09-09 Kao Corp Hair tonic
JPS63211214A (en) * 1987-02-26 1988-09-02 Sunstar Inc Hair tonic
JPS63284125A (en) * 1987-05-15 1988-11-21 Ichimaru Pharcos Co Ltd Testosterone 5alpha-reductase inhibitor
JPH01246211A (en) * 1987-12-10 1989-10-02 Pola Chem Ind Inc Hair-restoring or growing accelerator
JPH01233207A (en) * 1988-03-15 1989-09-19 Chiyuuwa Internatl:Kk Hair tonic
JPH0217118A (en) * 1988-07-05 1990-01-22 Zenichi Ogita Japanese and chinese drug for hair growth
JPH0217117A (en) * 1988-07-06 1990-01-22 Shin Nippon Koeki Kk Hair tonic
JPH0248514A (en) * 1988-08-11 1990-02-19 Shiseido Co Ltd Hair tonic
JPH0248515A (en) * 1988-08-11 1990-02-19 Shiseido Co Ltd Hair tonic
JPH02111710A (en) * 1988-10-20 1990-04-24 Akio Fujikawa Cosmetic composition
JPH02275815A (en) * 1989-04-17 1990-11-09 Kanebo Ltd Hair-tonic cosmetic
JPH0344312A (en) * 1989-07-04 1991-02-26 Tokugen Shu Production of hair tonic
JPH0366606A (en) * 1989-08-03 1991-03-22 Shimizu Takao Hair tonic of compound crude drug
JPH03188014A (en) * 1989-12-15 1991-08-16 Shiseido Co Ltd Cosmetic
JPH03188013A (en) * 1989-12-15 1991-08-16 Shiseido Co Ltd Testosterone-5alpha-reductase inhibitor
JPH05255102A (en) * 1992-03-13 1993-10-05 Shiseido Co Ltd Testosterone-5-alpha-reductase inhibitor
JPH06172132A (en) * 1992-12-11 1994-06-21 Lion Corp Hair growing agent composition
JPH06227949A (en) * 1993-02-05 1994-08-16 Tomomi Kai Hair growth agent
JPH07206647A (en) * 1994-01-26 1995-08-08 Shiseido Co Ltd Hair tonic
JPH07278003A (en) * 1994-04-11 1995-10-24 Narisu Keshohin:Kk Testosterone-5alpha-reductase inhibitor
JPH0826937A (en) * 1994-07-12 1996-01-30 Daimu Internatl Kk Hair-raising agent
JPH0873324A (en) * 1994-09-06 1996-03-19 Kao Corp Hair-tonic and hair-growing agent
JPH08127518A (en) * 1994-09-07 1996-05-21 Dai Ichi Seiyaku Co Ltd Composition for hair
JPH09176031A (en) * 1995-12-28 1997-07-08 Shiseido Co Ltd Use of coriandrum plant extract
JPH09221413A (en) * 1996-02-14 1997-08-26 Noevir Co Ltd Hair tonic
JPH1036229A (en) * 1996-07-18 1998-02-10 Mandamu:Kk Stevia extract and hair growth composition
JPH10265347A (en) * 1997-03-26 1998-10-06 Shiseido Co Ltd Agent for extending hair growth period
JPH10265349A (en) * 1997-03-26 1998-10-06 Shiseido Co Ltd Hair tonic
JP3472072B2 (en) * 1997-03-26 2003-12-02 株式会社資生堂 Hair growth extender

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10265349A (en) * 1997-03-26 1998-10-06 Shiseido Co Ltd Hair tonic
JP2000256175A (en) * 1999-03-15 2000-09-19 Rasheru Seiyaku Kk Cosmetic composition
JP2000302667A (en) * 1999-04-23 2000-10-31 Kobe Tennenbutsu Kagaku Kk Accelerator for ample breasts
JP2002173416A (en) * 2000-12-06 2002-06-21 Kao Corp Hair cosmetic
JP2002322050A (en) * 2001-04-25 2002-11-08 Kenji Uehara Hair growth agent
JP2003192541A (en) * 2001-12-26 2003-07-09 Pola Chem Ind Inc Hair growth-promoting agent and skin care preparation for hair growth
JP2005035903A (en) * 2003-07-16 2005-02-10 Lion Corp Hair-restoring and growing agent composition
WO2005034894A1 (en) * 2003-10-09 2005-04-21 Advangen, Inc. Hair growth stimulant composition
EP1727511A4 (en) * 2004-03-16 2010-04-28 Lg Household & Health Care Ltd Hair growth agent composition
JP2007051075A (en) * 2005-08-16 2007-03-01 Keio Gijuku Method for preparing plant extract, plant extract and its application
WO2009123211A1 (en) 2008-03-31 2009-10-08 株式会社資生堂 Agents for maturing, normalizing or stabilizing blood vessels and wrinkle-preventing and improving agents
WO2009154237A1 (en) 2008-06-18 2009-12-23 株式会社資生堂 Stabilizer for lymph vessel
EP2526955A1 (en) 2008-06-18 2012-11-28 Shiseido Co., Ltd. Lymphatic vessel stabilizer
KR101040011B1 (en) * 2009-01-30 2011-06-08 유형준 Demodex folliculorum germicide
JP2013245172A (en) * 2012-05-24 2013-12-09 Nippon Menaade Keshohin Kk Trichogenous agent
JP2014172896A (en) * 2013-03-12 2014-09-22 Kyoei Kagaku Kogyo Kk Hair composition
JP2016527258A (en) * 2013-07-29 2016-09-08 エボニック デグサ ゲーエムベーハーEvonik Degussa GmbH Formulation containing sphinganine
JP2017137314A (en) * 2016-02-03 2017-08-10 イチバンライフ株式会社 Composition for head
WO2017134837A1 (en) * 2016-02-03 2017-08-10 イチバンライフ株式会社 New-hair growth agent
CN115466713A (en) * 2022-09-30 2022-12-13 北京熙朵医疗美容门诊部有限公司 Hair follicle activating solution for CHT living cell hair transplantation technology and preparation method thereof

Similar Documents

Publication Publication Date Title
JPH10265347A (en) Agent for extending hair growth period
JPH10265350A (en) Hair tonic
JPH10265349A (en) Hair tonic
JP3670279B2 (en) Anti-acne composition containing polya cocos wolf fungus extract
KR20110036682A (en) COMPOSITIONS COMPRISING AN NFκB-INHIBITOR AND A NON-RETINOID COLLAGEN PROMOTER
JPH11240823A (en) Activator for hair papilla
JP2002097116A (en) Cell activator
EP0867169B1 (en) Hair growth phase extender composition
JP2000080029A (en) Mobility promoter of cell derived from trichocyte, promoter of collagen-degrading ability of cell derived from trichocyte, and trichocyte-growth promoter
KR100903283B1 (en) Hair growing material which contains a deer antler ingredient and its manufacturing method
KR101066797B1 (en) Hair growth agent composition
JPH10226628A (en) Hair papilla-activating agent
JPH1192343A (en) Agent for prolonging hair growth period
CN108042386A (en) Dermatologic preparation composition containing ginsenoside RF
US20070207114A1 (en) Hair Growth Agent Composition
JP3495261B2 (en) Hair restorer
JP2001139436A (en) Hair tonic and grower
JP3472072B2 (en) Hair growth extender
JP2002284648A (en) Composition for hair restorer
JPH10265348A (en) Hair tonic
JP2002205922A (en) Prolongation agent for anagen of hair
JP2003238365A (en) Hair grower
EP1082125B1 (en) Pharmaceutical or cosmetical use of an extract of ruscus aculeatus for the treatment of hair disorders
JP2000119145A (en) Prolongation agent for anagen hair
JP2000128741A (en) Hair papilla activator

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20031216

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040120

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20050208